^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=1 -------------------------

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.TARGET_1            
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=1 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             39    10631001 10631002 10631003    
                           11601002 11601006 11601007    
                           13031001 13031004 13581001    
                           13581010 13581014 13991001    
                           13991002 13991004 13991007    
                           13991009 13991010 16591001    
                           16591003 16591006 17601002    
                           17601003 17601005 17601007    
                           17601012 17601014 17601025    
                           17661002 17661004 17661006    
                           19691001 19731001 19731002    
                           19731004 19731006 19831001    
                           19831005 19831008 19901003    
      trtn            3    1 2 3                         
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=1 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      AVISITN         2    4 12                          
      SSNRISN         2    1 2                           


                          Dimensions

              Covariance Parameters             3
              Columns in X                     21
              Columns in Z                      0
              Subjects                         39
              Max Obs per Subject               2
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=1 -------------------------

                      The Mixed Procedure

                    Number of Observations

          Number of Observations Read              78
          Number of Observations Used              78
          Number of Observations Not Used           0


                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       217.03427861                
          1              1       207.95373831      0.00000000


                   Convergence criteria met.                    
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=1 -------------------------

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.5871
                UN(2,1)     id           0.2540
                UN(2,2)     id           1.4094


                        Fit Statistics

             -2 Res Log Likelihood           208.0
             AIC (Smaller is Better)         214.0
             AICC (Smaller is Better)        214.3
             BIC (Smaller is Better)         218.9
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=1 -------------------------

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   2          9.08          0.0107


                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      BASE                  1      34      58.05    <.0001
      trtn                  2      34       0.58    0.5637
      AVISITN               1      34       0.19    0.6650
      trtn*AVISITN          2      34       0.42    0.6606
      BASE*AVISITN          1      34       0.32    0.5744
      SSNRISN               1      34       0.81    0.3739
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=1 -------------------------

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      AVISITN*SSNRISN       1      34       0.01    0.9283


                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   1               4    -0.4967     0.2772     34
 trtn*AVISITN   1              12    -0.7303     0.4295     34
 trtn*AVISITN   2               4    -0.3904     0.2305     34
 trtn*AVISITN   2              12    -0.5901     0.3572     34
 trtn*AVISITN   3               4    -0.3472     0.2431     34
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=1 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   3              12    -0.1851     0.3767     34

                      Least Squares Means
 
                       Analysis
 Effect         trtn   Visit (N)    t Value   Pr > |t|    Alpha

 trtn*AVISITN   1               4     -1.79     0.0820     0.05
 trtn*AVISITN   1              12     -1.70     0.0982     0.05
 trtn*AVISITN   2               4     -1.69     0.0996     0.05
 trtn*AVISITN   2              12     -1.65     0.1077     0.05
 trtn*AVISITN   3               4     -1.43     0.1624     0.05
 trtn*AVISITN   3              12     -0.49     0.6263     0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=1 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                          Analysis
    Effect         trtn   Visit (N)       Lower       Upper

    trtn*AVISITN   1               4    -1.0600     0.06658
    trtn*AVISITN   1              12    -1.6030      0.1425
    trtn*AVISITN   2               4    -0.8589     0.07817
    trtn*AVISITN   2              12    -1.3160      0.1358
    trtn*AVISITN   3               4    -0.8413      0.1469
    trtn*AVISITN   3              12    -0.9506      0.5804


 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=1 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  1              4  1              12    0.2335
  trtn*AVISITN  1              4  2               4   -0.1064
  trtn*AVISITN  1              4  2              12   0.09337
  trtn*AVISITN  1              4  3               4   -0.1495
  trtn*AVISITN  1              4  3              12   -0.3116
  trtn*AVISITN  1             12  2               4   -0.3399
  trtn*AVISITN  1             12  2              12   -0.1402
  trtn*AVISITN  1             12  3               4   -0.3831
  trtn*AVISITN  1             12  3              12   -0.5452
  trtn*AVISITN  2              4  2              12    0.1997
  trtn*AVISITN  2              4  3               4  -0.04316
  trtn*AVISITN  2              4  3              12   -0.2052
  trtn*AVISITN  2             12  3               4   -0.2429
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=1 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  1              4  1              12    0.4413
  trtn*AVISITN  1              4  2               4    0.3245
  trtn*AVISITN  1              4  2              12    0.4402
  trtn*AVISITN  1              4  3               4    0.3285
  trtn*AVISITN  1              4  3              12    0.4545
  trtn*AVISITN  1             12  2               4    0.4763
  trtn*AVISITN  1             12  2              12    0.5027
  trtn*AVISITN  1             12  3               4    0.4811
  trtn*AVISITN  1             12  3              12    0.5090
  trtn*AVISITN  2              4  2              12    0.3671
  trtn*AVISITN  2              4  3               4    0.2839
  trtn*AVISITN  2              4  3              12    0.4258
  trtn*AVISITN  2             12  3               4    0.4159
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=1 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  1              4  1              12    34     0.53
trtn*AVISITN  1              4  2               4    34    -0.33
trtn*AVISITN  1              4  2              12  63.4     0.21
trtn*AVISITN  1              4  3               4    34    -0.46
trtn*AVISITN  1              4  3              12  61.9    -0.69
trtn*AVISITN  1             12  2               4  51.4    -0.71
trtn*AVISITN  1             12  2              12    34    -0.28
trtn*AVISITN  1             12  3               4  53.1    -0.80
trtn*AVISITN  1             12  3              12    34    -1.07
trtn*AVISITN  2              4  2              12    34     0.54
trtn*AVISITN  2              4  3               4    34    -0.15
trtn*AVISITN  2              4  3              12  55.7    -0.48
trtn*AVISITN  2             12  3               4  59.4    -0.58
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=1 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  1              4  1              12    0.6001
  trtn*AVISITN  1              4  2               4    0.7451
  trtn*AVISITN  1              4  2              12    0.8327
  trtn*AVISITN  1              4  3               4    0.6519
  trtn*AVISITN  1              4  3              12    0.4955
  trtn*AVISITN  1             12  2               4    0.4787
  trtn*AVISITN  1             12  2              12    0.7821
  trtn*AVISITN  1             12  3               4    0.4294
  trtn*AVISITN  1             12  3              12    0.2917
  trtn*AVISITN  2              4  2              12    0.5899
  trtn*AVISITN  2              4  3               4    0.8801
  trtn*AVISITN  2              4  3              12    0.6317
  trtn*AVISITN  2             12  3               4    0.5615
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=1 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  1              4  1              12    0.05
   trtn*AVISITN  1              4  2               4    0.05
   trtn*AVISITN  1              4  2              12    0.05
   trtn*AVISITN  1              4  3               4    0.05
   trtn*AVISITN  1              4  3              12    0.05
   trtn*AVISITN  1             12  2               4    0.05
   trtn*AVISITN  1             12  2              12    0.05
   trtn*AVISITN  1             12  3               4    0.05
   trtn*AVISITN  1             12  3              12    0.05
   trtn*AVISITN  2              4  2              12    0.05
   trtn*AVISITN  2              4  3               4    0.05
   trtn*AVISITN  2              4  3              12    0.05
   trtn*AVISITN  2             12  3               4    0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=1 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  1              4  1              12   -0.6633
  trtn*AVISITN  1              4  2               4   -0.7658
  trtn*AVISITN  1              4  2              12   -0.7861
  trtn*AVISITN  1              4  3               4   -0.8171
  trtn*AVISITN  1              4  3              12   -1.2202
  trtn*AVISITN  1             12  2               4   -1.2960
  trtn*AVISITN  1             12  2              12   -1.1618
  trtn*AVISITN  1             12  3               4   -1.3479
  trtn*AVISITN  1             12  3              12   -1.5795
  trtn*AVISITN  2              4  2              12   -0.5463
  trtn*AVISITN  2              4  3               4   -0.6202
  trtn*AVISITN  2              4  3              12   -1.0584
  trtn*AVISITN  2             12  3               4   -1.0751
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=1 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  1              4  1              12    1.1304
  trtn*AVISITN  1              4  2               4    0.5530
  trtn*AVISITN  1              4  2              12    0.9728
  trtn*AVISITN  1              4  3               4    0.5181
  trtn*AVISITN  1              4  3              12    0.5970
  trtn*AVISITN  1             12  2               4    0.6162
  trtn*AVISITN  1             12  2              12    0.8815
  trtn*AVISITN  1             12  3               4    0.5818
  trtn*AVISITN  1             12  3              12    0.4892
  trtn*AVISITN  2              4  2              12    0.9457
  trtn*AVISITN  2              4  3               4    0.5339
  trtn*AVISITN  2              4  3              12    0.6479
  trtn*AVISITN  2             12  3               4    0.5893
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=1 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  2             12  3              12   -0.4050
  trtn*AVISITN  3              4  3              12   -0.1621

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  2             12  3              12    0.4399
  trtn*AVISITN  3              4  3              12    0.3871

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=1 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  2             12  3              12    34    -0.92
trtn*AVISITN  3              4  3              12    34    -0.42

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  2             12  3              12    0.3637
  trtn*AVISITN  3              4  3              12    0.6780

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=1 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  2             12  3              12    0.05
   trtn*AVISITN  3              4  3              12    0.05

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  2             12  3              12   -1.2990
  trtn*AVISITN  3              4  3              12   -0.9488

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=1 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  2             12  3              12    0.4890
  trtn*AVISITN  3              4  3              12    0.6246
 
 
 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=2 -------------------------

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.TARGET_1            
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=2 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             39    10631001 10631002 10631003    
                           11601002 11601006 11601007    
                           13031001 13031004 13581001    
                           13581010 13581014 13991001    
                           13991002 13991004 13991007    
                           13991009 13991010 16591001    
                           16591003 16591006 17601002    
                           17601003 17601005 17601007    
                           17601012 17601014 17601025    
                           17661002 17661004 17661006    
                           19691001 19731001 19731002    
                           19731004 19731006 19831001    
                           19831005 19831008 19901003    
      trtn            3    1 2 3                         
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=2 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      AVISITN         2    4 12                          
      SSNRISN         2    1 2                           


                          Dimensions

              Covariance Parameters             3
              Columns in X                     21
              Columns in Z                      0
              Subjects                         39
              Max Obs per Subject               2
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=2 -------------------------

                      The Mixed Procedure

                    Number of Observations

          Number of Observations Read              78
          Number of Observations Used              78
          Number of Observations Not Used           0


                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       197.59572415                
          1              1       191.79708522      0.00000000


                   Convergence criteria met.                    
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=2 -------------------------

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.6788
                UN(2,1)     id           0.2883
                UN(2,2)     id           0.8213


                        Fit Statistics

             -2 Res Log Likelihood           191.8
             AIC (Smaller is Better)         197.8
             AICC (Smaller is Better)        198.2
             BIC (Smaller is Better)         202.8
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=2 -------------------------

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   2          5.80          0.0551


                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      BASE                  1      34      45.32    <.0001
      trtn                  2      34       0.10    0.9065
      AVISITN               1      34       1.96    0.1709
      trtn*AVISITN          2      34       0.16    0.8496
      BASE*AVISITN          1      34       1.65    0.2072
      SSNRISN               1      34       2.59    0.1171
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=2 -------------------------

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      AVISITN*SSNRISN       1      34       0.50    0.4859


                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   1               4    -0.4834     0.2980     34
 trtn*AVISITN   1              12    -0.8068     0.3278     34
 trtn*AVISITN   2               4    -0.4473     0.2479     34
 trtn*AVISITN   2              12    -0.5894     0.2727     34
 trtn*AVISITN   3               4    -0.4808     0.2614     34
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=2 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   3              12    -0.5743     0.2875     34

                      Least Squares Means
 
                       Analysis
 Effect         trtn   Visit (N)    t Value   Pr > |t|    Alpha

 trtn*AVISITN   1               4     -1.62     0.1141     0.05
 trtn*AVISITN   1              12     -2.46     0.0191     0.05
 trtn*AVISITN   2               4     -1.80     0.0800     0.05
 trtn*AVISITN   2              12     -2.16     0.0378     0.05
 trtn*AVISITN   3               4     -1.84     0.0746     0.05
 trtn*AVISITN   3              12     -2.00     0.0539     0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=2 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                          Analysis
    Effect         trtn   Visit (N)       Lower       Upper

    trtn*AVISITN   1               4    -1.0891      0.1223
    trtn*AVISITN   1              12    -1.4731     -0.1406
    trtn*AVISITN   2               4    -0.9511     0.05650
    trtn*AVISITN   2              12    -1.1435    -0.03524
    trtn*AVISITN   3               4    -1.0121     0.05042
    trtn*AVISITN   3              12    -1.1586     0.01010


 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=2 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  1              4  1              12    0.3234
  trtn*AVISITN  1              4  2               4  -0.03611
  trtn*AVISITN  1              4  2              12    0.1060
  trtn*AVISITN  1              4  3               4  -0.00257
  trtn*AVISITN  1              4  3              12   0.09088
  trtn*AVISITN  1             12  2               4   -0.3595
  trtn*AVISITN  1             12  2              12   -0.2174
  trtn*AVISITN  1             12  3               4   -0.3260
  trtn*AVISITN  1             12  3              12   -0.2326
  trtn*AVISITN  2              4  2              12    0.1421
  trtn*AVISITN  2              4  3               4   0.03354
  trtn*AVISITN  2              4  3              12    0.1270
  trtn*AVISITN  2             12  3               4   -0.1086
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=2 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  1              4  1              12    0.3476
  trtn*AVISITN  1              4  2               4    0.3489
  trtn*AVISITN  1              4  2              12    0.3887
  trtn*AVISITN  1              4  3               4    0.3532
  trtn*AVISITN  1              4  3              12    0.3972
  trtn*AVISITN  1             12  2               4    0.3960
  trtn*AVISITN  1             12  2              12    0.3838
  trtn*AVISITN  1             12  3               4    0.4026
  trtn*AVISITN  1             12  3              12    0.3885
  trtn*AVISITN  2              4  2              12    0.2891
  trtn*AVISITN  2              4  3               4    0.3053
  trtn*AVISITN  2              4  3              12    0.3586
  trtn*AVISITN  2             12  3               4    0.3566
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=2 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  1              4  1              12    34     0.93
trtn*AVISITN  1              4  2               4    34    -0.10
trtn*AVISITN  1              4  2              12  64.7     0.27
trtn*AVISITN  1              4  3               4    34    -0.01
trtn*AVISITN  1              4  3              12  65.5     0.23
trtn*AVISITN  1             12  2               4  60.7    -0.91
trtn*AVISITN  1             12  2              12    34    -0.57
trtn*AVISITN  1             12  3               4  62.4    -0.81
trtn*AVISITN  1             12  3              12    34    -0.60
trtn*AVISITN  2              4  2              12    34     0.49
trtn*AVISITN  2              4  3               4    34     0.11
trtn*AVISITN  2              4  3              12  65.5     0.35
trtn*AVISITN  2             12  3               4    67    -0.30
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=2 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  1              4  1              12    0.3587
  trtn*AVISITN  1              4  2               4    0.9182
  trtn*AVISITN  1              4  2              12    0.7859
  trtn*AVISITN  1              4  3               4    0.9942
  trtn*AVISITN  1              4  3              12    0.8197
  trtn*AVISITN  1             12  2               4    0.3675
  trtn*AVISITN  1             12  2              12    0.5747
  trtn*AVISITN  1             12  3               4    0.4211
  trtn*AVISITN  1             12  3              12    0.5534
  trtn*AVISITN  2              4  2              12    0.6262
  trtn*AVISITN  2              4  3               4    0.9132
  trtn*AVISITN  2              4  3              12    0.7244
  trtn*AVISITN  2             12  3               4    0.7617
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=2 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  1              4  1              12    0.05
   trtn*AVISITN  1              4  2               4    0.05
   trtn*AVISITN  1              4  2              12    0.05
   trtn*AVISITN  1              4  3               4    0.05
   trtn*AVISITN  1              4  3              12    0.05
   trtn*AVISITN  1             12  2               4    0.05
   trtn*AVISITN  1             12  2              12    0.05
   trtn*AVISITN  1             12  3               4    0.05
   trtn*AVISITN  1             12  3              12    0.05
   trtn*AVISITN  2              4  2              12    0.05
   trtn*AVISITN  2              4  3               4    0.05
   trtn*AVISITN  2              4  3              12    0.05
   trtn*AVISITN  2             12  3               4    0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=2 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  1              4  1              12   -0.3830
  trtn*AVISITN  1              4  2               4   -0.7451
  trtn*AVISITN  1              4  2              12   -0.6703
  trtn*AVISITN  1              4  3               4   -0.7204
  trtn*AVISITN  1              4  3              12   -0.7022
  trtn*AVISITN  1             12  2               4   -1.1514
  trtn*AVISITN  1             12  2              12   -0.9973
  trtn*AVISITN  1             12  3               4   -1.1306
  trtn*AVISITN  1             12  3              12   -1.0222
  trtn*AVISITN  2              4  2              12   -0.4455
  trtn*AVISITN  2              4  3               4   -0.5869
  trtn*AVISITN  2              4  3              12   -0.5891
  trtn*AVISITN  2             12  3               4   -0.8203
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=2 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  1              4  1              12    1.0299
  trtn*AVISITN  1              4  2               4    0.6729
  trtn*AVISITN  1              4  2              12    0.8823
  trtn*AVISITN  1              4  3               4    0.7153
  trtn*AVISITN  1              4  3              12    0.8840
  trtn*AVISITN  1             12  2               4    0.4323
  trtn*AVISITN  1             12  2              12    0.5625
  trtn*AVISITN  1             12  3               4    0.4786
  trtn*AVISITN  1             12  3              12    0.5571
  trtn*AVISITN  2              4  2              12    0.7297
  trtn*AVISITN  2              4  3               4    0.6540
  trtn*AVISITN  2              4  3              12    0.8430
  trtn*AVISITN  2             12  3               4    0.6032
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=2 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  2             12  3              12  -0.01512
  trtn*AVISITN  3              4  3              12   0.09344

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  2             12  3              12    0.3358
  trtn*AVISITN  3              4  3              12    0.3049

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=2 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  2             12  3              12    34    -0.05
trtn*AVISITN  3              4  3              12    34     0.31

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  2             12  3              12    0.9643
  trtn*AVISITN  3              4  3              12    0.7611

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=2 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  2             12  3              12    0.05
   trtn*AVISITN  3              4  3              12    0.05

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  2             12  3              12   -0.6976
  trtn*AVISITN  3              4  3              12   -0.5262

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=2 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  2             12  3              12    0.6673
  trtn*AVISITN  3              4  3              12    0.7131
 
 
 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=3 -------------------------

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.TARGET_1            
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=3 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             39    10631001 10631002 10631003    
                           11601002 11601006 11601007    
                           13031001 13031004 13581001    
                           13581010 13581014 13991001    
                           13991002 13991004 13991007    
                           13991009 13991010 16591001    
                           16591003 16591006 17601002    
                           17601003 17601005 17601007    
                           17601012 17601014 17601025    
                           17661002 17661004 17661006    
                           19691001 19731001 19731002    
                           19731004 19731006 19831001    
                           19831005 19831008 19901003    
      trtn            3    1 2 3                         
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=3 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      AVISITN         2    4 12                          
      SSNRISN         2    1 2                           


                          Dimensions

              Covariance Parameters             3
              Columns in X                     21
              Columns in Z                      0
              Subjects                         39
              Max Obs per Subject               2
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=3 -------------------------

                      The Mixed Procedure

                    Number of Observations

          Number of Observations Read              78
          Number of Observations Used              78
          Number of Observations Not Used           0


                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       194.37001430                
          1              1       191.31111720      0.00000000


                   Convergence criteria met.                    
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=3 -------------------------

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.5891
                UN(2,1)     id           0.1676
                UN(2,2)     id           0.8415


                        Fit Statistics

             -2 Res Log Likelihood           191.3
             AIC (Smaller is Better)         197.3
             AICC (Smaller is Better)        197.7
             BIC (Smaller is Better)         202.3
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=3 -------------------------

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   2          3.06          0.2167


                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      BASE                  1      34      64.89    <.0001
      trtn                  2      34       1.00    0.3770
      AVISITN               1      34       0.22    0.6437
      trtn*AVISITN          2      34       0.14    0.8715
      BASE*AVISITN          1      34       0.05    0.8296
      SSNRISN               1      34       1.42    0.2411
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=3 -------------------------

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      AVISITN*SSNRISN       1      34       0.11    0.7458


                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   1               4    -0.5089     0.2777     34
 trtn*AVISITN   1              12    -0.6459     0.3318     34
 trtn*AVISITN   2               4    -0.5886     0.2309     34
 trtn*AVISITN   2              12    -0.8283     0.2760     34
 trtn*AVISITN   3               4    -0.1777     0.2435     34
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=3 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   3              12    -0.5451     0.2911     34

                      Least Squares Means
 
                       Analysis
 Effect         trtn   Visit (N)    t Value   Pr > |t|    Alpha

 trtn*AVISITN   1               4     -1.83     0.0756     0.05
 trtn*AVISITN   1              12     -1.95     0.0599     0.05
 trtn*AVISITN   2               4     -2.55     0.0155     0.05
 trtn*AVISITN   2              12     -3.00     0.0050     0.05
 trtn*AVISITN   3               4     -0.73     0.4706     0.05
 trtn*AVISITN   3              12     -1.87     0.0697     0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=3 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                          Analysis
    Effect         trtn   Visit (N)       Lower       Upper

    trtn*AVISITN   1               4    -1.0731     0.05539
    trtn*AVISITN   1              12    -1.3202     0.02850
    trtn*AVISITN   2               4    -1.0579     -0.1193
    trtn*AVISITN   2              12    -1.3892     -0.2674
    trtn*AVISITN   3               4    -0.6726      0.3172
    trtn*AVISITN   3              12    -1.1366     0.04642


 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=3 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  1              4  1              12    0.1370
  trtn*AVISITN  1              4  2               4   0.07971
  trtn*AVISITN  1              4  2              12    0.3194
  trtn*AVISITN  1              4  3               4   -0.3312
  trtn*AVISITN  1              4  3              12   0.03620
  trtn*AVISITN  1             12  2               4  -0.05728
  trtn*AVISITN  1             12  2              12    0.1824
  trtn*AVISITN  1             12  3               4   -0.4682
  trtn*AVISITN  1             12  3              12   -0.1008
  trtn*AVISITN  2              4  2              12    0.2397
  trtn*AVISITN  2              4  3               4   -0.4109
  trtn*AVISITN  2              4  3              12  -0.04352
  trtn*AVISITN  2             12  3               4   -0.6506
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=3 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  1              4  1              12    0.3786
  trtn*AVISITN  1              4  2               4    0.3250
  trtn*AVISITN  1              4  2              12    0.3824
  trtn*AVISITN  1              4  3               4    0.3291
  trtn*AVISITN  1              4  3              12    0.3922
  trtn*AVISITN  1             12  2               4    0.3955
  trtn*AVISITN  1             12  2              12    0.3884
  trtn*AVISITN  1             12  3               4    0.4018
  trtn*AVISITN  1             12  3              12    0.3933
  trtn*AVISITN  2              4  2              12    0.3149
  trtn*AVISITN  2              4  3               4    0.2844
  trtn*AVISITN  2              4  3              12    0.3592
  trtn*AVISITN  2             12  3               4    0.3556
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=3 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  1              4  1              12    34     0.36
trtn*AVISITN  1              4  2               4    34     0.25
trtn*AVISITN  1              4  2              12  67.8     0.84
trtn*AVISITN  1              4  3               4    34    -1.01
trtn*AVISITN  1              4  3              12  67.8     0.09
trtn*AVISITN  1             12  2               4  60.3    -0.14
trtn*AVISITN  1             12  2              12    34     0.47
trtn*AVISITN  1             12  3               4  62.1    -1.17
trtn*AVISITN  1             12  3              12    34    -0.26
trtn*AVISITN  2              4  2              12    34     0.76
trtn*AVISITN  2              4  3               4    34    -1.44
trtn*AVISITN  2              4  3              12  64.3    -0.12
trtn*AVISITN  2             12  3               4  66.7    -1.83
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=3 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  1              4  1              12    0.7197
  trtn*AVISITN  1              4  2               4    0.8077
  trtn*AVISITN  1              4  2              12    0.4064
  trtn*AVISITN  1              4  3               4    0.3213
  trtn*AVISITN  1              4  3              12    0.9267
  trtn*AVISITN  1             12  2               4    0.8853
  trtn*AVISITN  1             12  2              12    0.6416
  trtn*AVISITN  1             12  3               4    0.2484
  trtn*AVISITN  1             12  3              12    0.7993
  trtn*AVISITN  2              4  2              12    0.4517
  trtn*AVISITN  2              4  3               4    0.1577
  trtn*AVISITN  2              4  3              12    0.9039
  trtn*AVISITN  2             12  3               4    0.0718
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=3 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  1              4  1              12    0.05
   trtn*AVISITN  1              4  2               4    0.05
   trtn*AVISITN  1              4  2              12    0.05
   trtn*AVISITN  1              4  3               4    0.05
   trtn*AVISITN  1              4  3              12    0.05
   trtn*AVISITN  1             12  2               4    0.05
   trtn*AVISITN  1             12  2              12    0.05
   trtn*AVISITN  1             12  3               4    0.05
   trtn*AVISITN  1             12  3              12    0.05
   trtn*AVISITN  2              4  2              12    0.05
   trtn*AVISITN  2              4  3               4    0.05
   trtn*AVISITN  2              4  3              12    0.05
   trtn*AVISITN  2             12  3               4    0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=3 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  1              4  1              12   -0.6324
  trtn*AVISITN  1              4  2               4   -0.5808
  trtn*AVISITN  1              4  2              12   -0.4436
  trtn*AVISITN  1              4  3               4   -0.9999
  trtn*AVISITN  1              4  3              12   -0.7464
  trtn*AVISITN  1             12  2               4   -0.8483
  trtn*AVISITN  1             12  2              12   -0.6070
  trtn*AVISITN  1             12  3               4   -1.2713
  trtn*AVISITN  1             12  3              12   -0.9000
  trtn*AVISITN  2              4  2              12   -0.4002
  trtn*AVISITN  2              4  3               4   -0.9889
  trtn*AVISITN  2              4  3              12   -0.7610
  trtn*AVISITN  2             12  3               4   -1.3604
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=3 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  1              4  1              12    0.9064
  trtn*AVISITN  1              4  2               4    0.7402
  trtn*AVISITN  1              4  2              12    1.0825
  trtn*AVISITN  1              4  3               4    0.3376
  trtn*AVISITN  1              4  3              12    0.8188
  trtn*AVISITN  1             12  2               4    0.7337
  trtn*AVISITN  1             12  2              12    0.9718
  trtn*AVISITN  1             12  3               4    0.3349
  trtn*AVISITN  1             12  3              12    0.6984
  trtn*AVISITN  2              4  2              12    0.8797
  trtn*AVISITN  2              4  3               4    0.1671
  trtn*AVISITN  2              4  3              12    0.6740
  trtn*AVISITN  2             12  3               4   0.05923
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=3 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  2             12  3              12   -0.2832
  trtn*AVISITN  3              4  3              12    0.3674

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  2             12  3              12    0.3399
  trtn*AVISITN  3              4  3              12    0.3321

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=3 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  2             12  3              12    34    -0.83
trtn*AVISITN  3              4  3              12    34     1.11

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  2             12  3              12    0.4105
  trtn*AVISITN  3              4  3              12    0.2764

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=3 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  2             12  3              12    0.05
   trtn*AVISITN  3              4  3              12    0.05

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  2             12  3              12   -0.9740
  trtn*AVISITN  3              4  3              12   -0.3075

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=3 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  2             12  3              12    0.4075
  trtn*AVISITN  3              4  3              12    1.0422
 
 
 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=4 -------------------------

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.TARGET_1            
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=4 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             39    10631001 10631002 10631003    
                           11601002 11601006 11601007    
                           13031001 13031004 13581001    
                           13581010 13581014 13991001    
                           13991002 13991004 13991007    
                           13991009 13991010 16591001    
                           16591003 16591006 17601002    
                           17601003 17601005 17601007    
                           17601012 17601014 17601025    
                           17661002 17661004 17661006    
                           19691001 19731001 19731002    
                           19731004 19731006 19831001    
                           19831005 19831008 19901003    
      trtn            3    1 2 3                         
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=4 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      AVISITN         2    4 12                          
      SSNRISN         2    1 2                           


                          Dimensions

              Covariance Parameters             3
              Columns in X                     21
              Columns in Z                      0
              Subjects                         39
              Max Obs per Subject               2
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=4 -------------------------

                      The Mixed Procedure

                    Number of Observations

          Number of Observations Read              78
          Number of Observations Used              78
          Number of Observations Not Used           0


                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       196.91348697                
          1              1       192.17515608      0.00000000


                   Convergence criteria met.                    
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=4 -------------------------

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.5868
                UN(2,1)     id           0.2178
                UN(2,2)     id           0.8983


                        Fit Statistics

             -2 Res Log Likelihood           192.2
             AIC (Smaller is Better)         198.2
             AICC (Smaller is Better)        198.6
             BIC (Smaller is Better)         203.2
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=4 -------------------------

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   2          4.74          0.0936


                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      BASE                  1      34      50.04    <.0001
      trtn                  2      34       0.21    0.8098
      AVISITN               1      34       0.19    0.6661
      trtn*AVISITN          2      34       0.08    0.9204
      BASE*AVISITN          1      34       0.08    0.7840
      SSNRISN               1      34       1.58    0.2167
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=4 -------------------------

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      AVISITN*SSNRISN       1      34       0.20    0.6558


                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   1               4    -0.5209     0.2771     34
 trtn*AVISITN   1              12    -0.7925     0.3429     34
 trtn*AVISITN   2               4    -0.4859     0.2305     34
 trtn*AVISITN   2              12    -0.6028     0.2852     34
 trtn*AVISITN   3               4    -0.4102     0.2430     34
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=4 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   3              12    -0.5164     0.3007     34

                      Least Squares Means
 
                       Analysis
 Effect         trtn   Visit (N)    t Value   Pr > |t|    Alpha

 trtn*AVISITN   1               4     -1.88     0.0687     0.05
 trtn*AVISITN   1              12     -2.31     0.0270     0.05
 trtn*AVISITN   2               4     -2.11     0.0425     0.05
 trtn*AVISITN   2              12     -2.11     0.0420     0.05
 trtn*AVISITN   3               4     -1.69     0.1006     0.05
 trtn*AVISITN   3              12     -1.72     0.0950     0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=4 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                          Analysis
    Effect         trtn   Visit (N)       Lower       Upper

    trtn*AVISITN   1               4    -1.0840     0.04223
    trtn*AVISITN   1              12    -1.4893    -0.09575
    trtn*AVISITN   2               4    -0.9543    -0.01751
    trtn*AVISITN   2              12    -1.1824    -0.02324
    trtn*AVISITN   3               4    -0.9041     0.08374
    trtn*AVISITN   3              12    -1.1276     0.09474


 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=4 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  1              4  1              12    0.2716
  trtn*AVISITN  1              4  2               4  -0.03500
  trtn*AVISITN  1              4  2              12   0.08190
  trtn*AVISITN  1              4  3               4   -0.1107
  trtn*AVISITN  1              4  3              12  -0.00449
  trtn*AVISITN  1             12  2               4   -0.3066
  trtn*AVISITN  1             12  2              12   -0.1897
  trtn*AVISITN  1             12  3               4   -0.3823
  trtn*AVISITN  1             12  3              12   -0.2761
  trtn*AVISITN  2              4  2              12    0.1169
  trtn*AVISITN  2              4  3               4  -0.07571
  trtn*AVISITN  2              4  3              12   0.03052
  trtn*AVISITN  2             12  3               4   -0.1926
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=4 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  1              4  1              12    0.3706
  trtn*AVISITN  1              4  2               4    0.3244
  trtn*AVISITN  1              4  2              12    0.3859
  trtn*AVISITN  1              4  3               4    0.3284
  trtn*AVISITN  1              4  3              12    0.3960
  trtn*AVISITN  1             12  2               4    0.4019
  trtn*AVISITN  1             12  2              12    0.4014
  trtn*AVISITN  1             12  3               4    0.4077
  trtn*AVISITN  1             12  3              12    0.4064
  trtn*AVISITN  2              4  2              12    0.3082
  trtn*AVISITN  2              4  3               4    0.2838
  trtn*AVISITN  2              4  3              12    0.3631
  trtn*AVISITN  2             12  3               4    0.3587
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=4 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  1              4  1              12    34     0.73
trtn*AVISITN  1              4  2               4    34    -0.11
trtn*AVISITN  1              4  2              12  67.1     0.21
trtn*AVISITN  1              4  3               4    34    -0.34
trtn*AVISITN  1              4  3              12  66.9    -0.01
trtn*AVISITN  1             12  2               4  58.6    -0.76
trtn*AVISITN  1             12  2              12    34    -0.47
trtn*AVISITN  1             12  3               4  60.5    -0.94
trtn*AVISITN  1             12  3              12    34    -0.68
trtn*AVISITN  2              4  2              12    34     0.38
trtn*AVISITN  2              4  3               4    34    -0.27
trtn*AVISITN  2              4  3              12  63.3     0.08
trtn*AVISITN  2             12  3               4  66.2    -0.54
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=4 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  1              4  1              12    0.4686
  trtn*AVISITN  1              4  2               4    0.9147
  trtn*AVISITN  1              4  2              12    0.8326
  trtn*AVISITN  1              4  3               4    0.7381
  trtn*AVISITN  1              4  3              12    0.9910
  trtn*AVISITN  1             12  2               4    0.4485
  trtn*AVISITN  1             12  2              12    0.6394
  trtn*AVISITN  1             12  3               4    0.3521
  trtn*AVISITN  1             12  3              12    0.5014
  trtn*AVISITN  2              4  2              12    0.7068
  trtn*AVISITN  2              4  3               4    0.7913
  trtn*AVISITN  2              4  3              12    0.9333
  trtn*AVISITN  2             12  3               4    0.5931
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=4 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  1              4  1              12    0.05
   trtn*AVISITN  1              4  2               4    0.05
   trtn*AVISITN  1              4  2              12    0.05
   trtn*AVISITN  1              4  3               4    0.05
   trtn*AVISITN  1              4  3              12    0.05
   trtn*AVISITN  1             12  2               4    0.05
   trtn*AVISITN  1             12  2              12    0.05
   trtn*AVISITN  1             12  3               4    0.05
   trtn*AVISITN  1             12  3              12    0.05
   trtn*AVISITN  2              4  2              12    0.05
   trtn*AVISITN  2              4  3               4    0.05
   trtn*AVISITN  2              4  3              12    0.05
   trtn*AVISITN  2             12  3               4    0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=4 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  1              4  1              12   -0.4815
  trtn*AVISITN  1              4  2               4   -0.6942
  trtn*AVISITN  1              4  2              12   -0.6884
  trtn*AVISITN  1              4  3               4   -0.7781
  trtn*AVISITN  1              4  3              12   -0.7950
  trtn*AVISITN  1             12  2               4   -1.1109
  trtn*AVISITN  1             12  2              12   -1.0054
  trtn*AVISITN  1             12  3               4   -1.1978
  trtn*AVISITN  1             12  3              12   -1.1019
  trtn*AVISITN  2              4  2              12   -0.5095
  trtn*AVISITN  2              4  3               4   -0.6526
  trtn*AVISITN  2              4  3              12   -0.6949
  trtn*AVISITN  2             12  3               4   -0.9087
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=4 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  1              4  1              12    1.0247
  trtn*AVISITN  1              4  2               4    0.6242
  trtn*AVISITN  1              4  2              12    0.8522
  trtn*AVISITN  1              4  3               4    0.5567
  trtn*AVISITN  1              4  3              12    0.7860
  trtn*AVISITN  1             12  2               4    0.4977
  trtn*AVISITN  1             12  2              12    0.6259
  trtn*AVISITN  1             12  3               4    0.4331
  trtn*AVISITN  1             12  3              12    0.5497
  trtn*AVISITN  2              4  2              12    0.7433
  trtn*AVISITN  2              4  3               4    0.5011
  trtn*AVISITN  2              4  3              12    0.7560
  trtn*AVISITN  2             12  3               4    0.5235
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=4 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  2             12  3              12  -0.08639
  trtn*AVISITN  3              4  3              12    0.1062

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  2             12  3              12    0.3512
  trtn*AVISITN  3              4  3              12    0.3250

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=4 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  2             12  3              12    34    -0.25
trtn*AVISITN  3              4  3              12    34     0.33

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  2             12  3              12    0.8072
  trtn*AVISITN  3              4  3              12    0.7458

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=4 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  2             12  3              12    0.05
   trtn*AVISITN  3              4  3              12    0.05

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  2             12  3              12   -0.8001
  trtn*AVISITN  3              4  3              12   -0.5543

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=4 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  2             12  3              12    0.6274
  trtn*AVISITN  3              4  3              12    0.7668
 
 
 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=5 -------------------------

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.TARGET_1            
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=5 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             39    10631001 10631002 10631003    
                           11601002 11601006 11601007    
                           13031001 13031004 13581001    
                           13581010 13581014 13991001    
                           13991002 13991004 13991007    
                           13991009 13991010 16591001    
                           16591003 16591006 17601002    
                           17601003 17601005 17601007    
                           17601012 17601014 17601025    
                           17661002 17661004 17661006    
                           19691001 19731001 19731002    
                           19731004 19731006 19831001    
                           19831005 19831008 19901003    
      trtn            3    1 2 3                         
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=5 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      AVISITN         2    4 12                          
      SSNRISN         2    1 2                           


                          Dimensions

              Covariance Parameters             3
              Columns in X                     21
              Columns in Z                      0
              Subjects                         39
              Max Obs per Subject               2
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=5 -------------------------

                      The Mixed Procedure

                    Number of Observations

          Number of Observations Read              78
          Number of Observations Used              78
          Number of Observations Not Used           0


                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       227.57720647                
          1              1       215.75979533      0.00000000


                   Convergence criteria met.                    
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=5 -------------------------

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.5664
                UN(2,1)     id           0.1996
                UN(2,2)     id           1.7649


                        Fit Statistics

             -2 Res Log Likelihood           215.8
             AIC (Smaller is Better)         221.8
             AICC (Smaller is Better)        222.1
             BIC (Smaller is Better)         226.8
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=5 -------------------------

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   2         11.82          0.0027


                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      BASE                  1      34      35.35    <.0001
      trtn                  2      34       0.70    0.5019
      AVISITN               1      34       0.07    0.7869
      trtn*AVISITN          2      34       0.37    0.6953
      BASE*AVISITN          1      34       0.10    0.7507
      SSNRISN               1      34       0.52    0.4764
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=5 -------------------------

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      AVISITN*SSNRISN       1      34       0.02    0.9015


                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   1               4    -0.5127     0.2723     34
 trtn*AVISITN   1              12    -0.7854     0.4806     34
 trtn*AVISITN   2               4    -0.5498     0.2264     34
 trtn*AVISITN   2              12    -0.4192     0.3997     34
 trtn*AVISITN   3               4    -0.3541     0.2388     34
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=5 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   3              12    -0.1326     0.4215     34

                      Least Squares Means
 
                       Analysis
 Effect         trtn   Visit (N)    t Value   Pr > |t|    Alpha

 trtn*AVISITN   1               4     -1.88     0.0683     0.05
 trtn*AVISITN   1              12     -1.63     0.1114     0.05
 trtn*AVISITN   2               4     -2.43     0.0206     0.05
 trtn*AVISITN   2              12     -1.05     0.3017     0.05
 trtn*AVISITN   3               4     -1.48     0.1473     0.05
 trtn*AVISITN   3              12     -0.31     0.7551     0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=5 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                          Analysis
    Effect         trtn   Visit (N)       Lower       Upper

    trtn*AVISITN   1               4    -1.0660     0.04061
    trtn*AVISITN   1              12    -1.7620      0.1913
    trtn*AVISITN   2               4    -1.0100    -0.08962
    trtn*AVISITN   2              12    -1.2315      0.3931
    trtn*AVISITN   3               4    -0.8394      0.1312
    trtn*AVISITN   3              12    -0.9892      0.7241


 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=5 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  1              4  1              12    0.2727
  trtn*AVISITN  1              4  2               4   0.03714
  trtn*AVISITN  1              4  2              12  -0.09348
  trtn*AVISITN  1              4  3               4   -0.1585
  trtn*AVISITN  1              4  3              12   -0.3801
  trtn*AVISITN  1             12  2               4   -0.2356
  trtn*AVISITN  1             12  2              12   -0.3662
  trtn*AVISITN  1             12  3               4   -0.4312
  trtn*AVISITN  1             12  3              12   -0.6528
  trtn*AVISITN  2              4  2              12   -0.1306
  trtn*AVISITN  2              4  3               4   -0.1957
  trtn*AVISITN  2              4  3              12   -0.4172
  trtn*AVISITN  2             12  3               4  -0.06506
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=5 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  1              4  1              12    0.5028
  trtn*AVISITN  1              4  2               4    0.3187
  trtn*AVISITN  1              4  2              12    0.4749
  trtn*AVISITN  1              4  3               4    0.3227
  trtn*AVISITN  1              4  3              12    0.4922
  trtn*AVISITN  1             12  2               4    0.5233
  trtn*AVISITN  1             12  2              12    0.5626
  trtn*AVISITN  1             12  3               4    0.5277
  trtn*AVISITN  1             12  3              12    0.5696
  trtn*AVISITN  2              4  2              12    0.4182
  trtn*AVISITN  2              4  3               4    0.2789
  trtn*AVISITN  2              4  3              12    0.4671
  trtn*AVISITN  2             12  3               4    0.4539
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=5 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  1              4  1              12    34     0.54
trtn*AVISITN  1              4  2               4    34     0.12
trtn*AVISITN  1              4  2              12  59.7    -0.20
trtn*AVISITN  1              4  3               4    34    -0.49
trtn*AVISITN  1              4  3              12  57.8    -0.77
trtn*AVISITN  1             12  2               4    48    -0.45
trtn*AVISITN  1             12  2              12    34    -0.65
trtn*AVISITN  1             12  3               4  49.4    -0.82
trtn*AVISITN  1             12  3              12    34    -1.15
trtn*AVISITN  2              4  2              12    34    -0.31
trtn*AVISITN  2              4  3               4    34    -0.70
trtn*AVISITN  2              4  3              12  51.4    -0.89
trtn*AVISITN  2             12  3               4  54.8    -0.14
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=5 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  1              4  1              12    0.5911
  trtn*AVISITN  1              4  2               4    0.9079
  trtn*AVISITN  1              4  2              12    0.8446
  trtn*AVISITN  1              4  3               4    0.6263
  trtn*AVISITN  1              4  3              12    0.4431
  trtn*AVISITN  1             12  2               4    0.6546
  trtn*AVISITN  1             12  2              12    0.5195
  trtn*AVISITN  1             12  3               4    0.4177
  trtn*AVISITN  1             12  3              12    0.2597
  trtn*AVISITN  2              4  2              12    0.7567
  trtn*AVISITN  2              4  3               4    0.4877
  trtn*AVISITN  2              4  3              12    0.3759
  trtn*AVISITN  2             12  3               4    0.8866
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=5 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  1              4  1              12    0.05
   trtn*AVISITN  1              4  2               4    0.05
   trtn*AVISITN  1              4  2              12    0.05
   trtn*AVISITN  1              4  3               4    0.05
   trtn*AVISITN  1              4  3              12    0.05
   trtn*AVISITN  1             12  2               4    0.05
   trtn*AVISITN  1             12  2              12    0.05
   trtn*AVISITN  1             12  3               4    0.05
   trtn*AVISITN  1             12  3              12    0.05
   trtn*AVISITN  2              4  2              12    0.05
   trtn*AVISITN  2              4  3               4    0.05
   trtn*AVISITN  2              4  3              12    0.05
   trtn*AVISITN  2             12  3               4    0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=5 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  1              4  1              12   -0.7492
  trtn*AVISITN  1              4  2               4   -0.6105
  trtn*AVISITN  1              4  2              12   -1.0435
  trtn*AVISITN  1              4  3               4   -0.8143
  trtn*AVISITN  1              4  3              12   -1.3654
  trtn*AVISITN  1             12  2               4   -1.2877
  trtn*AVISITN  1             12  2              12   -1.5094
  trtn*AVISITN  1             12  3               4   -1.4914
  trtn*AVISITN  1             12  3              12   -1.8103
  trtn*AVISITN  2              4  2              12   -0.9806
  trtn*AVISITN  2              4  3               4   -0.7624
  trtn*AVISITN  2              4  3              12   -1.3549
  trtn*AVISITN  2             12  3               4   -0.9748
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=5 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  1              4  1              12    1.2946
  trtn*AVISITN  1              4  2               4    0.6848
  trtn*AVISITN  1              4  2              12    0.8565
  trtn*AVISITN  1              4  3               4    0.4972
  trtn*AVISITN  1              4  3              12    0.6052
  trtn*AVISITN  1             12  2               4    0.8166
  trtn*AVISITN  1             12  2              12    0.7771
  trtn*AVISITN  1             12  3               4    0.6290
  trtn*AVISITN  1             12  3              12    0.5047
  trtn*AVISITN  2              4  2              12    0.7193
  trtn*AVISITN  2              4  3               4    0.3711
  trtn*AVISITN  2              4  3              12    0.5204
  trtn*AVISITN  2             12  3               4    0.8447
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=5 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  2             12  3              12   -0.2866
  trtn*AVISITN  3              4  3              12   -0.2216

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  2             12  3              12    0.4923
  trtn*AVISITN  3              4  3              12    0.4410

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=5 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  2             12  3              12    34    -0.58
trtn*AVISITN  3              4  3              12    34    -0.50

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  2             12  3              12    0.5642
  trtn*AVISITN  3              4  3              12    0.6186

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=5 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  2             12  3              12    0.05
   trtn*AVISITN  3              4  3              12    0.05

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  2             12  3              12   -1.2870
  trtn*AVISITN  3              4  3              12   -1.1179

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=5 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  2             12  3              12    0.7138
  trtn*AVISITN  3              4  3              12    0.6747
 
 
 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=6 -------------------------

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.TARGET_1            
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=6 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             39    10631001 10631002 10631003    
                           11601002 11601006 11601007    
                           13031001 13031004 13581001    
                           13581010 13581014 13991001    
                           13991002 13991004 13991007    
                           13991009 13991010 16591001    
                           16591003 16591006 17601002    
                           17601003 17601005 17601007    
                           17601012 17601014 17601025    
                           17661002 17661004 17661006    
                           19691001 19731001 19731002    
                           19731004 19731006 19831001    
                           19831005 19831008 19901003    
      trtn            3    1 2 3                         
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=6 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      AVISITN         2    4 12                          
      SSNRISN         2    1 2                           


                          Dimensions

              Covariance Parameters             3
              Columns in X                     21
              Columns in Z                      0
              Subjects                         39
              Max Obs per Subject               2
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=6 -------------------------

                      The Mixed Procedure

                    Number of Observations

          Number of Observations Read              78
          Number of Observations Used              78
          Number of Observations Not Used           0


                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       179.03211447                
          1              1       172.04138157      0.00000000


                   Convergence criteria met.                    
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=6 -------------------------

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.5411
                UN(2,1)     id           0.2443
                UN(2,2)     id           0.6006


                        Fit Statistics

             -2 Res Log Likelihood           172.0
             AIC (Smaller is Better)         178.0
             AICC (Smaller is Better)        178.4
             BIC (Smaller is Better)         183.0
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=6 -------------------------

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   2          6.99          0.0303


                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      BASE                  1      34      71.57    <.0001
      trtn                  2      34       0.07    0.9296
      AVISITN               1      34       2.23    0.1447
      trtn*AVISITN          2      34       0.00    0.9959
      BASE*AVISITN          1      34       0.63    0.4315
      SSNRISN               1      34       1.65    0.2073
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=6 -------------------------

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      AVISITN*SSNRISN       1      34       0.02    0.8849


                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   1               4    -0.4821     0.2661     34
 trtn*AVISITN   1              12    -1.0109     0.2803     34
 trtn*AVISITN   2               4    -0.4368     0.2213     34
 trtn*AVISITN   2              12    -0.9969     0.2332     34
 trtn*AVISITN   3               4    -0.3753     0.2334     34
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=6 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   3              12    -0.9233     0.2459     34

                      Least Squares Means
 
                       Analysis
 Effect         trtn   Visit (N)    t Value   Pr > |t|    Alpha

 trtn*AVISITN   1               4     -1.81     0.0789     0.05
 trtn*AVISITN   1              12     -3.61     0.0010     0.05
 trtn*AVISITN   2               4     -1.97     0.0566     0.05
 trtn*AVISITN   2              12     -4.28     0.0001     0.05
 trtn*AVISITN   3               4     -1.61     0.1171     0.05
 trtn*AVISITN   3              12     -3.75     0.0006     0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=6 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                          Analysis
    Effect         trtn   Visit (N)       Lower       Upper

    trtn*AVISITN   1               4    -1.0228     0.05874
    trtn*AVISITN   1              12    -1.5807     -0.4412
    trtn*AVISITN   2               4    -0.8866     0.01300
    trtn*AVISITN   2              12    -1.4707     -0.5230
    trtn*AVISITN   3               4    -0.8497     0.09900
    trtn*AVISITN   3              12    -1.4230     -0.4236


 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=6 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  1              4  1              12    0.5289
  trtn*AVISITN  1              4  2               4  -0.04524
  trtn*AVISITN  1              4  2              12    0.5148
  trtn*AVISITN  1              4  3               4   -0.1067
  trtn*AVISITN  1              4  3              12    0.4412
  trtn*AVISITN  1             12  2               4   -0.5741
  trtn*AVISITN  1             12  2              12  -0.01407
  trtn*AVISITN  1             12  3               4   -0.6356
  trtn*AVISITN  1             12  3              12  -0.08765
  trtn*AVISITN  2              4  2              12    0.5601
  trtn*AVISITN  2              4  3               4  -0.06148
  trtn*AVISITN  2              4  3              12    0.4865
  trtn*AVISITN  2             12  3               4   -0.6215
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=6 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  1              4  1              12    0.2923
  trtn*AVISITN  1              4  2               4    0.3115
  trtn*AVISITN  1              4  2              12    0.3390
  trtn*AVISITN  1              4  3               4    0.3154
  trtn*AVISITN  1              4  3              12    0.3459
  trtn*AVISITN  1             12  2               4    0.3425
  trtn*AVISITN  1             12  2              12    0.3282
  trtn*AVISITN  1             12  3               4    0.3484
  trtn*AVISITN  1             12  3              12    0.3323
  trtn*AVISITN  2              4  2              12    0.2432
  trtn*AVISITN  2              4  3               4    0.2726
  trtn*AVISITN  2              4  3              12    0.3103
  trtn*AVISITN  2             12  3               4    0.3093
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=6 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  1              4  1              12    34     1.81
trtn*AVISITN  1              4  2               4    34    -0.15
trtn*AVISITN  1              4  2              12  62.8     1.52
trtn*AVISITN  1              4  3               4    34    -0.34
trtn*AVISITN  1              4  3              12  63.8     1.28
trtn*AVISITN  1             12  2               4  60.7    -1.68
trtn*AVISITN  1             12  2              12    34    -0.04
trtn*AVISITN  1             12  3               4  62.2    -1.82
trtn*AVISITN  1             12  3              12    34    -0.26
trtn*AVISITN  2              4  2              12    34     2.30
trtn*AVISITN  2              4  3               4    34    -0.23
trtn*AVISITN  2              4  3              12  65.4     1.57
trtn*AVISITN  2             12  3               4  66.2    -2.01
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=6 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  1              4  1              12    0.0793
  trtn*AVISITN  1              4  2               4    0.8854
  trtn*AVISITN  1              4  2              12    0.1339
  trtn*AVISITN  1              4  3               4    0.7371
  trtn*AVISITN  1              4  3              12    0.2067
  trtn*AVISITN  1             12  2               4    0.0988
  trtn*AVISITN  1             12  2              12    0.9661
  trtn*AVISITN  1             12  3               4    0.0729
  trtn*AVISITN  1             12  3              12    0.7935
  trtn*AVISITN  2              4  2              12    0.0275
  trtn*AVISITN  2              4  3               4    0.8229
  trtn*AVISITN  2              4  3              12    0.1218
  trtn*AVISITN  2             12  3               4    0.0486
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=6 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  1              4  1              12    0.05
   trtn*AVISITN  1              4  2               4    0.05
   trtn*AVISITN  1              4  2              12    0.05
   trtn*AVISITN  1              4  3               4    0.05
   trtn*AVISITN  1              4  3              12    0.05
   trtn*AVISITN  1             12  2               4    0.05
   trtn*AVISITN  1             12  2              12    0.05
   trtn*AVISITN  1             12  3               4    0.05
   trtn*AVISITN  1             12  3              12    0.05
   trtn*AVISITN  2              4  2              12    0.05
   trtn*AVISITN  2              4  3               4    0.05
   trtn*AVISITN  2              4  3              12    0.05
   trtn*AVISITN  2             12  3               4    0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=6 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  1              4  1              12  -0.06525
  trtn*AVISITN  1              4  2               4   -0.6783
  trtn*AVISITN  1              4  2              12   -0.1626
  trtn*AVISITN  1              4  3               4   -0.7477
  trtn*AVISITN  1              4  3              12   -0.2497
  trtn*AVISITN  1             12  2               4   -1.2591
  trtn*AVISITN  1             12  2              12   -0.6810
  trtn*AVISITN  1             12  3               4   -1.3321
  trtn*AVISITN  1             12  3              12   -0.7629
  trtn*AVISITN  2              4  2              12   0.06588
  trtn*AVISITN  2              4  3               4   -0.6154
  trtn*AVISITN  2              4  3              12   -0.1332
  trtn*AVISITN  2             12  3               4   -1.2391
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=6 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  1              4  1              12    1.1230
  trtn*AVISITN  1              4  2               4    0.5878
  trtn*AVISITN  1              4  2              12    1.1922
  trtn*AVISITN  1              4  3               4    0.5342
  trtn*AVISITN  1              4  3              12    1.1322
  trtn*AVISITN  1             12  2               4    0.1108
  trtn*AVISITN  1             12  2              12    0.6528
  trtn*AVISITN  1             12  3               4   0.06087
  trtn*AVISITN  1             12  3              12    0.5876
  trtn*AVISITN  2              4  2              12    1.0542
  trtn*AVISITN  2              4  3               4    0.4925
  trtn*AVISITN  2              4  3              12    1.1061
  trtn*AVISITN  2             12  3               4  -0.00397
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=6 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  2             12  3              12  -0.07358
  trtn*AVISITN  3              4  3              12    0.5480

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  2             12  3              12    0.2872
  trtn*AVISITN  3              4  3              12    0.2564

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=6 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  2             12  3              12    34    -0.26
trtn*AVISITN  3              4  3              12    34     2.14

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  2             12  3              12    0.7993
  trtn*AVISITN  3              4  3              12    0.0399

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=6 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  2             12  3              12    0.05
   trtn*AVISITN  3              4  3              12    0.05

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  2             12  3              12   -0.6572
  trtn*AVISITN  3              4  3              12   0.02684

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=6 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  2             12  3              12    0.5100
  trtn*AVISITN  3              4  3              12    1.0691
 
 
 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=7 -------------------------

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.TARGET_1            
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=7 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             39    10631001 10631002 10631003    
                           11601002 11601006 11601007    
                           13031001 13031004 13581001    
                           13581010 13581014 13991001    
                           13991002 13991004 13991007    
                           13991009 13991010 16591001    
                           16591003 16591006 17601002    
                           17601003 17601005 17601007    
                           17601012 17601014 17601025    
                           17661002 17661004 17661006    
                           19691001 19731001 19731002    
                           19731004 19731006 19831001    
                           19831005 19831008 19901003    
      trtn            3    1 2 3                         
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=7 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      AVISITN         2    4 12                          
      SSNRISN         2    1 2                           


                          Dimensions

              Covariance Parameters             3
              Columns in X                     21
              Columns in Z                      0
              Subjects                         39
              Max Obs per Subject               2
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=7 -------------------------

                      The Mixed Procedure

                    Number of Observations

          Number of Observations Read              78
          Number of Observations Used              78
          Number of Observations Not Used           0


                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       178.93662366                
          1              1       166.75305167      0.00000000


                   Convergence criteria met.                    
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=7 -------------------------

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.6086
                UN(2,1)     id           0.3105
                UN(2,2)     id           0.5316


                        Fit Statistics

             -2 Res Log Likelihood           166.8
             AIC (Smaller is Better)         172.8
             AICC (Smaller is Better)        173.1
             BIC (Smaller is Better)         177.7
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=7 -------------------------

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   2         12.18          0.0023


                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      BASE                  1      34      56.98    <.0001
      trtn                  2      34       0.01    0.9865
      AVISITN               1      34       1.94    0.1729
      trtn*AVISITN          2      34       0.57    0.5726
      BASE*AVISITN          1      34       0.84    0.3649
      SSNRISN               1      34       4.37    0.0442
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=7 -------------------------

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      AVISITN*SSNRISN       1      34       3.42    0.0731


                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   1               4    -0.5007     0.2822     34
 trtn*AVISITN   1              12    -0.7166     0.2637     34
 trtn*AVISITN   2               4    -0.4975     0.2347     34
 trtn*AVISITN   2              12    -0.8106     0.2194     34
 trtn*AVISITN   3               4    -0.3833     0.2475     34
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=7 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   3              12    -0.9061     0.2313     34

                      Least Squares Means
 
                       Analysis
 Effect         trtn   Visit (N)    t Value   Pr > |t|    Alpha

 trtn*AVISITN   1               4     -1.77     0.0850     0.05
 trtn*AVISITN   1              12     -2.72     0.0103     0.05
 trtn*AVISITN   2               4     -2.12     0.0414     0.05
 trtn*AVISITN   2              12     -3.69     0.0008     0.05
 trtn*AVISITN   3               4     -1.55     0.1308     0.05
 trtn*AVISITN   3              12     -3.92     0.0004     0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=7 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                          Analysis
    Effect         trtn   Visit (N)       Lower       Upper

    trtn*AVISITN   1               4    -1.0742     0.07283
    trtn*AVISITN   1              12    -1.2526     -0.1806
    trtn*AVISITN   2               4    -0.9745    -0.02049
    trtn*AVISITN   2              12    -1.2564     -0.3647
    trtn*AVISITN   3               4    -0.8863      0.1198
    trtn*AVISITN   3              12    -1.3763     -0.4360


 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=7 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  1              4  1              12    0.2160
  trtn*AVISITN  1              4  2               4  -0.00317
  trtn*AVISITN  1              4  2              12    0.3099
  trtn*AVISITN  1              4  3               4   -0.1174
  trtn*AVISITN  1              4  3              12    0.4055
  trtn*AVISITN  1             12  2               4   -0.2191
  trtn*AVISITN  1             12  2              12   0.09394
  trtn*AVISITN  1             12  3               4   -0.3334
  trtn*AVISITN  1             12  3              12    0.1895
  trtn*AVISITN  2              4  2              12    0.3131
  trtn*AVISITN  2              4  3               4   -0.1142
  trtn*AVISITN  2              4  3              12    0.4086
  trtn*AVISITN  2             12  3               4   -0.4273
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=7 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  1              4  1              12    0.2607
  trtn*AVISITN  1              4  2               4    0.3303
  trtn*AVISITN  1              4  2              12    0.3387
  trtn*AVISITN  1              4  3               4    0.3345
  trtn*AVISITN  1              4  3              12    0.3440
  trtn*AVISITN  1             12  2               4    0.3341
  trtn*AVISITN  1             12  2              12    0.3087
  trtn*AVISITN  1             12  3               4    0.3406
  trtn*AVISITN  1             12  3              12    0.3126
  trtn*AVISITN  2              4  2              12    0.2168
  trtn*AVISITN  2              4  3               4    0.2891
  trtn*AVISITN  2              4  3              12    0.3031
  trtn*AVISITN  2             12  3               4    0.3044
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=7 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  1              4  1              12    34     0.83
trtn*AVISITN  1              4  2               4    34    -0.01
trtn*AVISITN  1              4  2              12  56.1     0.92
trtn*AVISITN  1              4  3               4    34    -0.35
trtn*AVISITN  1              4  3              12  57.5     1.18
trtn*AVISITN  1             12  2               4  58.2    -0.66
trtn*AVISITN  1             12  2              12    34     0.30
trtn*AVISITN  1             12  3               4  59.2    -0.98
trtn*AVISITN  1             12  3              12    34     0.61
trtn*AVISITN  2              4  2              12    34     1.44
trtn*AVISITN  2              4  3               4    34    -0.40
trtn*AVISITN  2              4  3              12    62     1.35
trtn*AVISITN  2             12  3               4  61.1    -1.40
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=7 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  1              4  1              12    0.4132
  trtn*AVISITN  1              4  2               4    0.9924
  trtn*AVISITN  1              4  2              12    0.3641
  trtn*AVISITN  1              4  3               4    0.7277
  trtn*AVISITN  1              4  3              12    0.2434
  trtn*AVISITN  1             12  2               4    0.5144
  trtn*AVISITN  1             12  2              12    0.7628
  trtn*AVISITN  1             12  3               4    0.3317
  trtn*AVISITN  1             12  3              12    0.5483
  trtn*AVISITN  2              4  2              12    0.1579
  trtn*AVISITN  2              4  3               4    0.6951
  trtn*AVISITN  2              4  3              12    0.1825
  trtn*AVISITN  2             12  3               4    0.1654
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=7 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  1              4  1              12    0.05
   trtn*AVISITN  1              4  2               4    0.05
   trtn*AVISITN  1              4  2              12    0.05
   trtn*AVISITN  1              4  3               4    0.05
   trtn*AVISITN  1              4  3              12    0.05
   trtn*AVISITN  1             12  2               4    0.05
   trtn*AVISITN  1             12  2              12    0.05
   trtn*AVISITN  1             12  3               4    0.05
   trtn*AVISITN  1             12  3              12    0.05
   trtn*AVISITN  2              4  2              12    0.05
   trtn*AVISITN  2              4  3               4    0.05
   trtn*AVISITN  2              4  3              12    0.05
   trtn*AVISITN  2             12  3               4    0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=7 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  1              4  1              12   -0.3138
  trtn*AVISITN  1              4  2               4   -0.6745
  trtn*AVISITN  1              4  2              12   -0.3685
  trtn*AVISITN  1              4  3               4   -0.7971
  trtn*AVISITN  1              4  3              12   -0.2832
  trtn*AVISITN  1             12  2               4   -0.8877
  trtn*AVISITN  1             12  2              12   -0.5335
  trtn*AVISITN  1             12  3               4   -1.0149
  trtn*AVISITN  1             12  3              12   -0.4457
  trtn*AVISITN  2              4  2              12   -0.1275
  trtn*AVISITN  2              4  3               4   -0.7017
  trtn*AVISITN  2              4  3              12   -0.1973
  trtn*AVISITN  2             12  3               4   -1.0360
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=7 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  1              4  1              12    0.7457
  trtn*AVISITN  1              4  2               4    0.6682
  trtn*AVISITN  1              4  2              12    0.9883
  trtn*AVISITN  1              4  3               4    0.5623
  trtn*AVISITN  1              4  3              12    1.0942
  trtn*AVISITN  1             12  2               4    0.4495
  trtn*AVISITN  1             12  2              12    0.7214
  trtn*AVISITN  1             12  3               4    0.3481
  trtn*AVISITN  1             12  3              12    0.8248
  trtn*AVISITN  2              4  2              12    0.7537
  trtn*AVISITN  2              4  3               4    0.4732
  trtn*AVISITN  2              4  3              12    1.0146
  trtn*AVISITN  2             12  3               4    0.1813
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=7 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  2             12  3              12   0.09558
  trtn*AVISITN  3              4  3              12    0.5229

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  2             12  3              12    0.2702
  trtn*AVISITN  3              4  3              12    0.2286

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=7 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  2             12  3              12    34     0.35
trtn*AVISITN  3              4  3              12    34     2.29

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  2             12  3              12    0.7257
  trtn*AVISITN  3              4  3              12    0.0285

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=7 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  2             12  3              12    0.05
   trtn*AVISITN  3              4  3              12    0.05

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  2             12  3              12   -0.4535
  trtn*AVISITN  3              4  3              12   0.05827

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=7 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  2             12  3              12    0.6446
  trtn*AVISITN  3              4  3              12    0.9875
 
 
 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=8 -------------------------

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.TARGET_1            
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=8 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             39    10631001 10631002 10631003    
                           11601002 11601006 11601007    
                           13031001 13031004 13581001    
                           13581010 13581014 13991001    
                           13991002 13991004 13991007    
                           13991009 13991010 16591001    
                           16591003 16591006 17601002    
                           17601003 17601005 17601007    
                           17601012 17601014 17601025    
                           17661002 17661004 17661006    
                           19691001 19731001 19731002    
                           19731004 19731006 19831001    
                           19831005 19831008 19901003    
      trtn            3    1 2 3                         
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=8 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      AVISITN         2    4 12                          
      SSNRISN         2    1 2                           


                          Dimensions

              Covariance Parameters             3
              Columns in X                     21
              Columns in Z                      0
              Subjects                         39
              Max Obs per Subject               2
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=8 -------------------------

                      The Mixed Procedure

                    Number of Observations

          Number of Observations Read              78
          Number of Observations Used              78
          Number of Observations Not Used           0


                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       181.28937802                
          1              1       176.89351385      0.00000000


                   Convergence criteria met.                    
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=8 -------------------------

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.6329
                UN(2,1)     id           0.2010
                UN(2,2)     id           0.5473


                        Fit Statistics

             -2 Res Log Likelihood           176.9
             AIC (Smaller is Better)         182.9
             AICC (Smaller is Better)        183.3
             BIC (Smaller is Better)         187.9
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=8 -------------------------

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   2          4.40          0.1110


                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      BASE                  1      34      82.65    <.0001
      trtn                  2      34       0.66    0.5211
      AVISITN               1      34       0.16    0.6919
      trtn*AVISITN          2      34       2.31    0.1151
      BASE*AVISITN          1      34       1.01    0.3229
      SSNRISN               1      34       5.47    0.0254
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=8 -------------------------

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      AVISITN*SSNRISN       1      34       2.95    0.0949


                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   1               4    -0.5038     0.2878     34
 trtn*AVISITN   1              12    -0.5056     0.2676     34
 trtn*AVISITN   2               4    -0.4798     0.2394     34
 trtn*AVISITN   2              12    -0.8929     0.2226     34
 trtn*AVISITN   3               4    -0.4120     0.2524     34
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=8 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   3              12    -1.2187     0.2347     34

                      Least Squares Means
 
                       Analysis
 Effect         trtn   Visit (N)    t Value   Pr > |t|    Alpha

 trtn*AVISITN   1               4     -1.75     0.0890     0.05
 trtn*AVISITN   1              12     -1.89     0.0674     0.05
 trtn*AVISITN   2               4     -2.00     0.0530     0.05
 trtn*AVISITN   2              12     -4.01     0.0003     0.05
 trtn*AVISITN   3               4     -1.63     0.1119     0.05
 trtn*AVISITN   3              12     -5.19     <.0001     0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=8 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                          Analysis
    Effect         trtn   Visit (N)       Lower       Upper

    trtn*AVISITN   1               4    -1.0887     0.08103
    trtn*AVISITN   1              12    -1.0495     0.03832
    trtn*AVISITN   2               4    -0.9663    0.006662
    trtn*AVISITN   2              12    -1.3453     -0.4405
    trtn*AVISITN   3               4    -0.9249      0.1010
    trtn*AVISITN   3              12    -1.6957     -0.7416


 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=8 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  1              4  1              12  0.001751
  trtn*AVISITN  1              4  2               4  -0.02402
  trtn*AVISITN  1              4  2              12    0.3891
  trtn*AVISITN  1              4  3               4  -0.09185
  trtn*AVISITN  1              4  3              12    0.7149
  trtn*AVISITN  1             12  2               4  -0.02577
  trtn*AVISITN  1             12  2              12    0.3873
  trtn*AVISITN  1             12  3               4  -0.09360
  trtn*AVISITN  1             12  3              12    0.7131
  trtn*AVISITN  2              4  2              12    0.4131
  trtn*AVISITN  2              4  3               4  -0.06783
  trtn*AVISITN  2              4  3              12    0.7389
  trtn*AVISITN  2             12  3               4   -0.4809
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=8 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  1              4  1              12    0.3191
  trtn*AVISITN  1              4  2               4    0.3369
  trtn*AVISITN  1              4  2              12    0.3520
  trtn*AVISITN  1              4  3               4    0.3411
  trtn*AVISITN  1              4  3              12    0.3582
  trtn*AVISITN  1             12  2               4    0.3471
  trtn*AVISITN  1             12  2              12    0.3133
  trtn*AVISITN  1             12  3               4    0.3546
  trtn*AVISITN  1             12  3              12    0.3172
  trtn*AVISITN  2              4  2              12    0.2654
  trtn*AVISITN  2              4  3               4    0.2948
  trtn*AVISITN  2              4  3              12    0.3187
  trtn*AVISITN  2             12  3               4    0.3201
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=8 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  1              4  1              12    34     0.01
trtn*AVISITN  1              4  2               4    34    -0.07
trtn*AVISITN  1              4  2              12  62.3     1.11
trtn*AVISITN  1              4  3               4    34    -0.27
trtn*AVISITN  1              4  3              12    64     2.00
trtn*AVISITN  1             12  2               4  65.5    -0.07
trtn*AVISITN  1             12  2              12    34     1.24
trtn*AVISITN  1             12  3               4  66.4    -0.26
trtn*AVISITN  1             12  3              12    34     2.25
trtn*AVISITN  2              4  2              12    34     1.56
trtn*AVISITN  2              4  3               4    34    -0.23
trtn*AVISITN  2              4  3              12  67.7     2.32
trtn*AVISITN  2             12  3               4  66.6    -1.50
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=8 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  1              4  1              12    0.9957
  trtn*AVISITN  1              4  2               4    0.9436
  trtn*AVISITN  1              4  2              12    0.2733
  trtn*AVISITN  1              4  3               4    0.7893
  trtn*AVISITN  1              4  3              12    0.0502
  trtn*AVISITN  1             12  2               4    0.9410
  trtn*AVISITN  1             12  2              12    0.2248
  trtn*AVISITN  1             12  3               4    0.7926
  trtn*AVISITN  1             12  3              12    0.0312
  trtn*AVISITN  2              4  2              12    0.1289
  trtn*AVISITN  2              4  3               4    0.8194
  trtn*AVISITN  2              4  3              12    0.0235
  trtn*AVISITN  2             12  3               4    0.1377
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=8 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  1              4  1              12    0.05
   trtn*AVISITN  1              4  2               4    0.05
   trtn*AVISITN  1              4  2              12    0.05
   trtn*AVISITN  1              4  3               4    0.05
   trtn*AVISITN  1              4  3              12    0.05
   trtn*AVISITN  1             12  2               4    0.05
   trtn*AVISITN  1             12  2              12    0.05
   trtn*AVISITN  1             12  3               4    0.05
   trtn*AVISITN  1             12  3              12    0.05
   trtn*AVISITN  2              4  2              12    0.05
   trtn*AVISITN  2              4  3               4    0.05
   trtn*AVISITN  2              4  3              12    0.05
   trtn*AVISITN  2             12  3               4    0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=8 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  1              4  1              12   -0.6468
  trtn*AVISITN  1              4  2               4   -0.7086
  trtn*AVISITN  1              4  2              12   -0.3145
  trtn*AVISITN  1              4  3               4   -0.7850
  trtn*AVISITN  1              4  3              12  -0.00080
  trtn*AVISITN  1             12  2               4   -0.7188
  trtn*AVISITN  1             12  2              12   -0.2494
  trtn*AVISITN  1             12  3               4   -0.8015
  trtn*AVISITN  1             12  3              12   0.06851
  trtn*AVISITN  2              4  2              12   -0.1263
  trtn*AVISITN  2              4  3               4   -0.6669
  trtn*AVISITN  2              4  3              12    0.1029
  trtn*AVISITN  2             12  3               4   -1.1198
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=8 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  1              4  1              12    0.6503
  trtn*AVISITN  1              4  2               4    0.6606
  trtn*AVISITN  1              4  2              12    1.0927
  trtn*AVISITN  1              4  3               4    0.6013
  trtn*AVISITN  1              4  3              12    1.4305
  trtn*AVISITN  1             12  2               4    0.6673
  trtn*AVISITN  1             12  2              12    1.0240
  trtn*AVISITN  1             12  3               4    0.6143
  trtn*AVISITN  1             12  3              12    1.3577
  trtn*AVISITN  2              4  2              12    0.9525
  trtn*AVISITN  2              4  3               4    0.5313
  trtn*AVISITN  2              4  3              12    1.3749
  trtn*AVISITN  2             12  3               4    0.1580
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=8 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  2             12  3              12    0.3258
  trtn*AVISITN  3              4  3              12    0.8067

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  2             12  3              12    0.2741
  trtn*AVISITN  3              4  3              12    0.2799

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=8 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  2             12  3              12    34     1.19
trtn*AVISITN  3              4  3              12    34     2.88

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  2             12  3              12    0.2429
  trtn*AVISITN  3              4  3              12    0.0068

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=8 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  2             12  3              12    0.05
   trtn*AVISITN  3              4  3              12    0.05

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  2             12  3              12   -0.2313
  trtn*AVISITN  3              4  3              12    0.2379

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=8 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  2             12  3              12    0.8829
  trtn*AVISITN  3              4  3              12    1.3755
 
 
 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=9 -------------------------

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.TARGET_1            
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=9 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             39    10631001 10631002 10631003    
                           11601002 11601006 11601007    
                           13031001 13031004 13581001    
                           13581010 13581014 13991001    
                           13991002 13991004 13991007    
                           13991009 13991010 16591001    
                           16591003 16591006 17601002    
                           17601003 17601005 17601007    
                           17601012 17601014 17601025    
                           17661002 17661004 17661006    
                           19691001 19731001 19731002    
                           19731004 19731006 19831001    
                           19831005 19831008 19901003    
      trtn            3    1 2 3                         
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=9 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      AVISITN         2    4 12                          
      SSNRISN         2    1 2                           


                          Dimensions

              Covariance Parameters             3
              Columns in X                     21
              Columns in Z                      0
              Subjects                         39
              Max Obs per Subject               2
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=9 -------------------------

                      The Mixed Procedure

                    Number of Observations

          Number of Observations Read              78
          Number of Observations Used              78
          Number of Observations Not Used           0


                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       250.37590480                
          1              1       231.90902787      0.00000000


                   Convergence criteria met.                    
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=9 -------------------------

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.6116
                UN(2,1)     id           0.2762
                UN(2,2)     id           2.6483


                        Fit Statistics

             -2 Res Log Likelihood           231.9
             AIC (Smaller is Better)         237.9
             AICC (Smaller is Better)        238.3
             BIC (Smaller is Better)         242.9
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=9 -------------------------

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   2         18.47          <.0001


                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      BASE                  1      34      22.82    <.0001
      trtn                  2      34       1.08    0.3497
      AVISITN               1      34       0.66    0.4231
      trtn*AVISITN          2      34       0.46    0.6370
      BASE*AVISITN          1      34       0.73    0.3993
      SSNRISN               1      34       0.02    0.8876
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=9 -------------------------

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      AVISITN*SSNRISN       1      34       0.39    0.5381


                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   1               4    -0.5086     0.2829     34
 trtn*AVISITN   1              12    -0.8988     0.5887     34
 trtn*AVISITN   2               4    -0.5379     0.2353     34
 trtn*AVISITN   2              12    -0.5497     0.4897     34
 trtn*AVISITN   3               4    -0.2788     0.2481     34
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=9 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   3              12   0.003985     0.5163     34

                      Least Squares Means
 
                       Analysis
 Effect         trtn   Visit (N)    t Value   Pr > |t|    Alpha

 trtn*AVISITN   1               4     -1.80     0.0811     0.05
 trtn*AVISITN   1              12     -1.53     0.1361     0.05
 trtn*AVISITN   2               4     -2.29     0.0286     0.05
 trtn*AVISITN   2              12     -1.12     0.2695     0.05
 trtn*AVISITN   3               4     -1.12     0.2691     0.05
 trtn*AVISITN   3              12      0.01     0.9939     0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=9 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                          Analysis
    Effect         trtn   Visit (N)       Lower       Upper

    trtn*AVISITN   1               4    -1.0835     0.06631
    trtn*AVISITN   1              12    -2.0951      0.2976
    trtn*AVISITN   2               4    -1.0161    -0.05967
    trtn*AVISITN   2              12    -1.5448      0.4454
    trtn*AVISITN   3               4    -0.7831      0.2255
    trtn*AVISITN   3              12    -1.0454      1.0533


 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=9 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  1              4  1              12    0.3902
  trtn*AVISITN  1              4  2               4   0.02926
  trtn*AVISITN  1              4  2              12   0.04108
  trtn*AVISITN  1              4  3               4   -0.2298
  trtn*AVISITN  1              4  3              12   -0.5126
  trtn*AVISITN  1             12  2               4   -0.3609
  trtn*AVISITN  1             12  2              12   -0.3491
  trtn*AVISITN  1             12  3               4   -0.6200
  trtn*AVISITN  1             12  3              12   -0.9028
  trtn*AVISITN  2              4  2              12   0.01182
  trtn*AVISITN  2              4  3               4   -0.2591
  trtn*AVISITN  2              4  3              12   -0.5418
  trtn*AVISITN  2             12  3               4   -0.2709
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=9 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  1              4  1              12    0.5952
  trtn*AVISITN  1              4  2               4    0.3312
  trtn*AVISITN  1              4  2              12    0.5551
  trtn*AVISITN  1              4  3               4    0.3353
  trtn*AVISITN  1              4  3              12    0.5775
  trtn*AVISITN  1             12  2               4    0.6247
  trtn*AVISITN  1             12  2              12    0.6891
  trtn*AVISITN  1             12  3               4    0.6285
  trtn*AVISITN  1             12  3              12    0.6977
  trtn*AVISITN  2              4  2              12    0.4951
  trtn*AVISITN  2              4  3               4    0.2898
  trtn*AVISITN  2              4  3              12    0.5542
  trtn*AVISITN  2             12  3               4    0.5352
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=9 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  1              4  1              12    34     0.66
trtn*AVISITN  1              4  2               4    34     0.09
trtn*AVISITN  1              4  2              12    54     0.07
trtn*AVISITN  1              4  3               4    34    -0.69
trtn*AVISITN  1              4  3              12  52.3    -0.89
trtn*AVISITN  1             12  2               4  44.2    -0.58
trtn*AVISITN  1             12  2              12    34    -0.51
trtn*AVISITN  1             12  3               4  45.3    -0.99
trtn*AVISITN  1             12  3              12    34    -1.29
trtn*AVISITN  2              4  2              12    34     0.02
trtn*AVISITN  2              4  3               4    34    -0.89
trtn*AVISITN  2              4  3              12  46.9    -0.98
trtn*AVISITN  2             12  3               4  49.7    -0.51
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=9 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  1              4  1              12    0.5166
  trtn*AVISITN  1              4  2               4    0.9301
  trtn*AVISITN  1              4  2              12    0.9413
  trtn*AVISITN  1              4  3               4    0.4977
  trtn*AVISITN  1              4  3              12    0.3788
  trtn*AVISITN  1             12  2               4    0.5664
  trtn*AVISITN  1             12  2              12    0.6157
  trtn*AVISITN  1             12  3               4    0.3291
  trtn*AVISITN  1             12  3              12    0.2044
  trtn*AVISITN  2              4  2              12    0.9811
  trtn*AVISITN  2              4  3               4    0.3776
  trtn*AVISITN  2              4  3              12    0.3332
  trtn*AVISITN  2             12  3               4    0.6150
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=9 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  1              4  1              12    0.05
   trtn*AVISITN  1              4  2               4    0.05
   trtn*AVISITN  1              4  2              12    0.05
   trtn*AVISITN  1              4  3               4    0.05
   trtn*AVISITN  1              4  3              12    0.05
   trtn*AVISITN  1             12  2               4    0.05
   trtn*AVISITN  1             12  2              12    0.05
   trtn*AVISITN  1             12  3               4    0.05
   trtn*AVISITN  1             12  3              12    0.05
   trtn*AVISITN  2              4  2              12    0.05
   trtn*AVISITN  2              4  3               4    0.05
   trtn*AVISITN  2              4  3              12    0.05
   trtn*AVISITN  2             12  3               4    0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=9 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  1              4  1              12   -0.8195
  trtn*AVISITN  1              4  2               4   -0.6437
  trtn*AVISITN  1              4  2              12   -1.0719
  trtn*AVISITN  1              4  3               4   -0.9112
  trtn*AVISITN  1              4  3              12   -1.6712
  trtn*AVISITN  1             12  2               4   -1.6198
  trtn*AVISITN  1             12  2              12   -1.7496
  trtn*AVISITN  1             12  3               4   -1.8855
  trtn*AVISITN  1             12  3              12   -2.3207
  trtn*AVISITN  2              4  2              12   -0.9943
  trtn*AVISITN  2              4  3               4   -0.8480
  trtn*AVISITN  2              4  3              12   -1.6568
  trtn*AVISITN  2             12  3               4   -1.3461
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=9 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  1              4  1              12    1.5998
  trtn*AVISITN  1              4  2               4    0.7023
  trtn*AVISITN  1              4  2              12    1.1540
  trtn*AVISITN  1              4  3               4    0.4516
  trtn*AVISITN  1              4  3              12    0.6460
  trtn*AVISITN  1             12  2               4    0.8980
  trtn*AVISITN  1             12  2              12    1.0514
  trtn*AVISITN  1             12  3               4    0.6456
  trtn*AVISITN  1             12  3              12    0.5152
  trtn*AVISITN  2              4  2              12    1.0180
  trtn*AVISITN  2              4  3               4    0.3298
  trtn*AVISITN  2              4  3              12    0.5731
  trtn*AVISITN  2             12  3               4    0.8043
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=9 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  2             12  3              12   -0.5537
  trtn*AVISITN  3              4  3              12   -0.2828

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  2             12  3              12    0.6030
  trtn*AVISITN  3              4  3              12    0.5221

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=9 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  2             12  3              12    34    -0.92
trtn*AVISITN  3              4  3              12    34    -0.54

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  2             12  3              12    0.3650
  trtn*AVISITN  3              4  3              12    0.5916

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=9 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  2             12  3              12    0.05
   trtn*AVISITN  3              4  3              12    0.05

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  2             12  3              12   -1.7792
  trtn*AVISITN  3              4  3              12   -1.3438

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------- Imputation=9 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  2             12  3              12    0.6718
  trtn*AVISITN  3              4  3              12    0.7782
 
 
 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=10 -------------------------

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.TARGET_1            
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=10 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             39    10631001 10631002 10631003    
                           11601002 11601006 11601007    
                           13031001 13031004 13581001    
                           13581010 13581014 13991001    
                           13991002 13991004 13991007    
                           13991009 13991010 16591001    
                           16591003 16591006 17601002    
                           17601003 17601005 17601007    
                           17601012 17601014 17601025    
                           17661002 17661004 17661006    
                           19691001 19731001 19731002    
                           19731004 19731006 19831001    
                           19831005 19831008 19901003    
      trtn            3    1 2 3                         
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=10 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      AVISITN         2    4 12                          
      SSNRISN         2    1 2                           


                          Dimensions

              Covariance Parameters             3
              Columns in X                     21
              Columns in Z                      0
              Subjects                         39
              Max Obs per Subject               2
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=10 -------------------------

                      The Mixed Procedure

                    Number of Observations

          Number of Observations Read              78
          Number of Observations Used              78
          Number of Observations Not Used           0


                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       216.41767563                
          1              1       207.70052051      0.00000000


                   Convergence criteria met.                    
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=10 -------------------------

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.5890
                UN(2,1)     id           0.2473
                UN(2,2)     id           1.3894


                        Fit Statistics

             -2 Res Log Likelihood           207.7
             AIC (Smaller is Better)         213.7
             AICC (Smaller is Better)        214.1
             BIC (Smaller is Better)         218.7
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=10 -------------------------

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   2          8.72          0.0128


                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      BASE                  1      34      42.16    <.0001
      trtn                  2      34       0.57    0.5713
      AVISITN               1      34       0.38    0.5436
      trtn*AVISITN          2      34       0.52    0.6007
      BASE*AVISITN          1      34       0.25    0.6225
      SSNRISN               1      34       1.05    0.3125
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=10 -------------------------

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      AVISITN*SSNRISN       1      34       0.02    0.8780


                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   1               4    -0.4993     0.2776     34
 trtn*AVISITN   1              12    -0.8824     0.4264     34
 trtn*AVISITN   2               4    -0.4515     0.2309     34
 trtn*AVISITN   2              12    -0.6871     0.3547     34
 trtn*AVISITN   3               4    -0.4042     0.2435     34
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=10 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   3              12    -0.2952     0.3740     34

                      Least Squares Means
 
                       Analysis
 Effect         trtn   Visit (N)    t Value   Pr > |t|    Alpha

 trtn*AVISITN   1               4     -1.80     0.0810     0.05
 trtn*AVISITN   1              12     -2.07     0.0462     0.05
 trtn*AVISITN   2               4     -1.96     0.0588     0.05
 trtn*AVISITN   2              12     -1.94     0.0610     0.05
 trtn*AVISITN   3               4     -1.66     0.1062     0.05
 trtn*AVISITN   3              12     -0.79     0.4355     0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=10 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                          Analysis
    Effect         trtn   Visit (N)       Lower       Upper

    trtn*AVISITN   1               4    -1.0636     0.06490
    trtn*AVISITN   1              12    -1.7489    -0.01584
    trtn*AVISITN   2               4    -0.9208     0.01779
    trtn*AVISITN   2              12    -1.4079     0.03362
    trtn*AVISITN   3               4    -0.8991     0.09070
    trtn*AVISITN   3              12    -1.0552      0.4649


 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=10 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  1              4  1              12    0.3831
  trtn*AVISITN  1              4  2               4  -0.04781
  trtn*AVISITN  1              4  2              12    0.1878
  trtn*AVISITN  1              4  3               4  -0.09513
  trtn*AVISITN  1              4  3              12   -0.2042
  trtn*AVISITN  1             12  2               4   -0.4309
  trtn*AVISITN  1             12  2              12   -0.1952
  trtn*AVISITN  1             12  3               4   -0.4782
  trtn*AVISITN  1             12  3              12   -0.5872
  trtn*AVISITN  2              4  2              12    0.2356
  trtn*AVISITN  2              4  3               4  -0.04732
  trtn*AVISITN  2              4  3              12   -0.1564
  trtn*AVISITN  2             12  3               4   -0.2830
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=10 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  1              4  1              12    0.4407
  trtn*AVISITN  1              4  2               4    0.3250
  trtn*AVISITN  1              4  2              12    0.4387
  trtn*AVISITN  1              4  3               4    0.3290
  trtn*AVISITN  1              4  3              12    0.4529
  trtn*AVISITN  1             12  2               4    0.4741
  trtn*AVISITN  1             12  2              12    0.4991
  trtn*AVISITN  1             12  3               4    0.4789
  trtn*AVISITN  1             12  3              12    0.5054
  trtn*AVISITN  2              4  2              12    0.3665
  trtn*AVISITN  2              4  3               4    0.2844
  trtn*AVISITN  2              4  3              12    0.4241
  trtn*AVISITN  2             12  3               4    0.4144
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=10 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  1              4  1              12    34     0.87
trtn*AVISITN  1              4  2               4    34    -0.15
trtn*AVISITN  1              4  2              12  63.7     0.43
trtn*AVISITN  1              4  3               4    34    -0.29
trtn*AVISITN  1              4  3              12  62.2    -0.45
trtn*AVISITN  1             12  2               4  51.7    -0.91
trtn*AVISITN  1             12  2              12    34    -0.39
trtn*AVISITN  1             12  3               4  53.4    -1.00
trtn*AVISITN  1             12  3              12    34    -1.16
trtn*AVISITN  2              4  2              12    34     0.64
trtn*AVISITN  2              4  3               4    34    -0.17
trtn*AVISITN  2              4  3              12    56    -0.37
trtn*AVISITN  2             12  3               4  59.7    -0.68
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=10 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  1              4  1              12    0.3908
  trtn*AVISITN  1              4  2               4    0.8839
  trtn*AVISITN  1              4  2              12    0.6700
  trtn*AVISITN  1              4  3               4    0.7742
  trtn*AVISITN  1              4  3              12    0.6537
  trtn*AVISITN  1             12  2               4    0.3676
  trtn*AVISITN  1             12  2              12    0.6981
  trtn*AVISITN  1             12  3               4    0.3225
  trtn*AVISITN  1             12  3              12    0.2533
  trtn*AVISITN  2              4  2              12    0.5246
  trtn*AVISITN  2              4  3               4    0.8688
  trtn*AVISITN  2              4  3              12    0.7138
  trtn*AVISITN  2             12  3               4    0.4974
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=10 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  1              4  1              12    0.05
   trtn*AVISITN  1              4  2               4    0.05
   trtn*AVISITN  1              4  2              12    0.05
   trtn*AVISITN  1              4  3               4    0.05
   trtn*AVISITN  1              4  3              12    0.05
   trtn*AVISITN  1             12  2               4    0.05
   trtn*AVISITN  1             12  2              12    0.05
   trtn*AVISITN  1             12  3               4    0.05
   trtn*AVISITN  1             12  3              12    0.05
   trtn*AVISITN  2              4  2              12    0.05
   trtn*AVISITN  2              4  3               4    0.05
   trtn*AVISITN  2              4  3              12    0.05
   trtn*AVISITN  2             12  3               4    0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=10 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  1              4  1              12   -0.5124
  trtn*AVISITN  1              4  2               4   -0.7083
  trtn*AVISITN  1              4  2              12   -0.6887
  trtn*AVISITN  1              4  3               4   -0.7638
  trtn*AVISITN  1              4  3              12   -1.1095
  trtn*AVISITN  1             12  2               4   -1.3823
  trtn*AVISITN  1             12  2              12   -1.2096
  trtn*AVISITN  1             12  3               4   -1.4385
  trtn*AVISITN  1             12  3              12   -1.6143
  trtn*AVISITN  2              4  2              12   -0.5092
  trtn*AVISITN  2              4  3               4   -0.6253
  trtn*AVISITN  2              4  3              12   -1.0060
  trtn*AVISITN  2             12  3               4   -1.1120
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=10 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  1              4  1              12    1.2786
  trtn*AVISITN  1              4  2               4    0.6127
  trtn*AVISITN  1              4  2              12    1.0643
  trtn*AVISITN  1              4  3               4    0.5736
  trtn*AVISITN  1              4  3              12    0.7012
  trtn*AVISITN  1             12  2               4    0.5206
  trtn*AVISITN  1             12  2              12    0.8191
  trtn*AVISITN  1             12  3               4    0.4821
  trtn*AVISITN  1             12  3              12    0.4398
  trtn*AVISITN  2              4  2              12    0.9805
  trtn*AVISITN  2              4  3               4    0.5306
  trtn*AVISITN  2              4  3              12    0.6933
  trtn*AVISITN  2             12  3               4    0.5461
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=10 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  2             12  3              12   -0.3920
  trtn*AVISITN  3              4  3              12   -0.1090

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  2             12  3              12    0.4368
  trtn*AVISITN  3              4  3              12    0.3865

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=10 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  2             12  3              12    34    -0.90
trtn*AVISITN  3              4  3              12    34    -0.28

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  2             12  3              12    0.3758
  trtn*AVISITN  3              4  3              12    0.7796

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=10 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  2             12  3              12    0.05
   trtn*AVISITN  3              4  3              12    0.05

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  2             12  3              12   -1.2796
  trtn*AVISITN  3              4  3              12   -0.8945

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=10 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  2             12  3              12    0.4957
  trtn*AVISITN  3              4  3              12    0.6764
 
 
 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=11 -------------------------

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.TARGET_1            
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=11 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             39    10631001 10631002 10631003    
                           11601002 11601006 11601007    
                           13031001 13031004 13581001    
                           13581010 13581014 13991001    
                           13991002 13991004 13991007    
                           13991009 13991010 16591001    
                           16591003 16591006 17601002    
                           17601003 17601005 17601007    
                           17601012 17601014 17601025    
                           17661002 17661004 17661006    
                           19691001 19731001 19731002    
                           19731004 19731006 19831001    
                           19831005 19831008 19901003    
      trtn            3    1 2 3                         
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=11 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      AVISITN         2    4 12                          
      SSNRISN         2    1 2                           


                          Dimensions

              Covariance Parameters             3
              Columns in X                     21
              Columns in Z                      0
              Subjects                         39
              Max Obs per Subject               2
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=11 -------------------------

                      The Mixed Procedure

                    Number of Observations

          Number of Observations Read              78
          Number of Observations Used              78
          Number of Observations Not Used           0


                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       230.26638504                
          1              1       223.60392236      0.00000000


                   Convergence criteria met.                    
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=11 -------------------------

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.7137
                UN(2,1)     id           0.1126
                UN(2,2)     id           1.7117


                        Fit Statistics

             -2 Res Log Likelihood           223.6
             AIC (Smaller is Better)         229.6
             AICC (Smaller is Better)        230.0
             BIC (Smaller is Better)         234.6
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=11 -------------------------

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   2          6.66          0.0357


                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      BASE                  1      34      32.66    <.0001
      trtn                  2      34       0.67    0.5193
      AVISITN               1      34       0.00    0.9684
      trtn*AVISITN          2      34       0.60    0.5571
      BASE*AVISITN          1      34       0.00    0.9597
      SSNRISN               1      34       0.57    0.4559
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=11 -------------------------

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      AVISITN*SSNRISN       1      34       0.01    0.9353


                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   1               4    -0.5290     0.3056     34
 trtn*AVISITN   1              12    -0.8484     0.4733     34
 trtn*AVISITN   2               4    -0.5353     0.2542     34
 trtn*AVISITN   2              12    -0.5485     0.3937     34
 trtn*AVISITN   3               4    -0.4824     0.2680     34
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=11 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   3              12    -0.1229     0.4151     34

                      Least Squares Means
 
                       Analysis
 Effect         trtn   Visit (N)    t Value   Pr > |t|    Alpha

 trtn*AVISITN   1               4     -1.73     0.0925     0.05
 trtn*AVISITN   1              12     -1.79     0.0819     0.05
 trtn*AVISITN   2               4     -2.11     0.0427     0.05
 trtn*AVISITN   2              12     -1.39     0.1726     0.05
 trtn*AVISITN   3               4     -1.80     0.0808     0.05
 trtn*AVISITN   3              12     -0.30     0.7690     0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=11 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                          Analysis
    Effect         trtn   Visit (N)       Lower       Upper

    trtn*AVISITN   1               4    -1.1500     0.09207
    trtn*AVISITN   1              12    -1.8103      0.1134
    trtn*AVISITN   2               4    -1.0519    -0.01876
    trtn*AVISITN   2              12    -1.3485      0.2515
    trtn*AVISITN   3               4    -1.0271     0.06237
    trtn*AVISITN   3              12    -0.9665      0.7208


 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=11 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  1              4  1              12    0.3195
  trtn*AVISITN  1              4  2               4  0.006342
  trtn*AVISITN  1              4  2              12   0.01950
  trtn*AVISITN  1              4  3               4  -0.04662
  trtn*AVISITN  1              4  3              12   -0.4061
  trtn*AVISITN  1             12  2               4   -0.3131
  trtn*AVISITN  1             12  2              12   -0.3000
  trtn*AVISITN  1             12  3               4   -0.3661
  trtn*AVISITN  1             12  3              12   -0.7256
  trtn*AVISITN  2              4  2              12   0.01316
  trtn*AVISITN  2              4  3               4  -0.05296
  trtn*AVISITN  2              4  3              12   -0.4125
  trtn*AVISITN  2             12  3               4  -0.06613
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=11 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  1              4  1              12    0.5366
  trtn*AVISITN  1              4  2               4    0.3577
  trtn*AVISITN  1              4  2              12    0.4936
  trtn*AVISITN  1              4  3               4    0.3622
  trtn*AVISITN  1              4  3              12    0.5102
  trtn*AVISITN  1             12  2               4    0.5328
  trtn*AVISITN  1             12  2              12    0.5540
  trtn*AVISITN  1             12  3               4    0.5389
  trtn*AVISITN  1             12  3              12    0.5609
  trtn*AVISITN  2              4  2              12    0.4463
  trtn*AVISITN  2              4  3               4    0.3130
  trtn*AVISITN  2              4  3              12    0.4805
  trtn*AVISITN  2             12  3               4    0.4698
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=11 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  1              4  1              12    34     0.60
trtn*AVISITN  1              4  2               4    34     0.02
trtn*AVISITN  1              4  2              12  63.5     0.04
trtn*AVISITN  1              4  3               4    34    -0.13
trtn*AVISITN  1              4  3              12  61.8    -0.80
trtn*AVISITN  1             12  2               4  51.7    -0.59
trtn*AVISITN  1             12  2              12    34    -0.54
trtn*AVISITN  1             12  3               4  53.2    -0.68
trtn*AVISITN  1             12  3              12    34    -1.29
trtn*AVISITN  2              4  2              12    34     0.03
trtn*AVISITN  2              4  3               4    34    -0.17
trtn*AVISITN  2              4  3              12  54.9    -0.86
trtn*AVISITN  2             12  3               4  58.2    -0.14
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=11 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  1              4  1              12    0.5555
  trtn*AVISITN  1              4  2               4    0.9860
  trtn*AVISITN  1              4  2              12    0.9686
  trtn*AVISITN  1              4  3               4    0.8983
  trtn*AVISITN  1              4  3              12    0.4291
  trtn*AVISITN  1             12  2               4    0.5593
  trtn*AVISITN  1             12  2              12    0.5917
  trtn*AVISITN  1             12  3               4    0.4999
  trtn*AVISITN  1             12  3              12    0.2045
  trtn*AVISITN  2              4  2              12    0.9766
  trtn*AVISITN  2              4  3               4    0.8666
  trtn*AVISITN  2              4  3              12    0.3944
  trtn*AVISITN  2             12  3               4    0.8886
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=11 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  1              4  1              12    0.05
   trtn*AVISITN  1              4  2               4    0.05
   trtn*AVISITN  1              4  2              12    0.05
   trtn*AVISITN  1              4  3               4    0.05
   trtn*AVISITN  1              4  3              12    0.05
   trtn*AVISITN  1             12  2               4    0.05
   trtn*AVISITN  1             12  2              12    0.05
   trtn*AVISITN  1             12  3               4    0.05
   trtn*AVISITN  1             12  3              12    0.05
   trtn*AVISITN  2              4  2              12    0.05
   trtn*AVISITN  2              4  3               4    0.05
   trtn*AVISITN  2              4  3              12    0.05
   trtn*AVISITN  2             12  3               4    0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=11 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  1              4  1              12   -0.7710
  trtn*AVISITN  1              4  2               4   -0.7207
  trtn*AVISITN  1              4  2              12   -0.9667
  trtn*AVISITN  1              4  3               4   -0.7827
  trtn*AVISITN  1              4  3              12   -1.4261
  trtn*AVISITN  1             12  2               4   -1.3824
  trtn*AVISITN  1             12  2              12   -1.4259
  trtn*AVISITN  1             12  3               4   -1.4470
  trtn*AVISITN  1             12  3              12   -1.8655
  trtn*AVISITN  2              4  2              12   -0.8938
  trtn*AVISITN  2              4  3               4   -0.6891
  trtn*AVISITN  2              4  3              12   -1.3754
  trtn*AVISITN  2             12  3               4   -1.0065
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=11 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  1              4  1              12    1.4099
  trtn*AVISITN  1              4  2               4    0.7333
  trtn*AVISITN  1              4  2              12    1.0057
  trtn*AVISITN  1              4  3               4    0.6894
  trtn*AVISITN  1              4  3              12    0.6139
  trtn*AVISITN  1             12  2               4    0.7562
  trtn*AVISITN  1             12  2              12    0.8259
  trtn*AVISITN  1             12  3               4    0.7148
  trtn*AVISITN  1             12  3              12    0.4143
  trtn*AVISITN  2              4  2              12    0.9202
  trtn*AVISITN  2              4  3               4    0.5832
  trtn*AVISITN  2              4  3              12    0.5505
  trtn*AVISITN  2             12  3               4    0.8743
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=11 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  2             12  3              12   -0.4256
  trtn*AVISITN  3              4  3              12   -0.3595

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  2             12  3              12    0.4848
  trtn*AVISITN  3              4  3              12    0.4706

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=11 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  2             12  3              12    34    -0.88
trtn*AVISITN  3              4  3              12    34    -0.76

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  2             12  3              12    0.3861
  trtn*AVISITN  3              4  3              12    0.4502

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=11 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  2             12  3              12    0.05
   trtn*AVISITN  3              4  3              12    0.05

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  2             12  3              12   -1.4108
  trtn*AVISITN  3              4  3              12   -1.3159

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=11 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  2             12  3              12    0.5596
  trtn*AVISITN  3              4  3              12    0.5970
 
 
 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=12 -------------------------

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.TARGET_1            
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=12 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             39    10631001 10631002 10631003    
                           11601002 11601006 11601007    
                           13031001 13031004 13581001    
                           13581010 13581014 13991001    
                           13991002 13991004 13991007    
                           13991009 13991010 16591001    
                           16591003 16591006 17601002    
                           17601003 17601005 17601007    
                           17601012 17601014 17601025    
                           17661002 17661004 17661006    
                           19691001 19731001 19731002    
                           19731004 19731006 19831001    
                           19831005 19831008 19901003    
      trtn            3    1 2 3                         
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=12 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      AVISITN         2    4 12                          
      SSNRISN         2    1 2                           


                          Dimensions

              Covariance Parameters             3
              Columns in X                     21
              Columns in Z                      0
              Subjects                         39
              Max Obs per Subject               2
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=12 -------------------------

                      The Mixed Procedure

                    Number of Observations

          Number of Observations Read              78
          Number of Observations Used              78
          Number of Observations Not Used           0


                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       178.88175820                
          1              1       168.51159901      0.00000000


                   Convergence criteria met.                    
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=12 -------------------------

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.5969
                UN(2,1)     id           0.2908
                UN(2,2)     id           0.5423


                        Fit Statistics

             -2 Res Log Likelihood           168.5
             AIC (Smaller is Better)         174.5
             AICC (Smaller is Better)        174.9
             BIC (Smaller is Better)         179.5
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=12 -------------------------

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   2         10.37          0.0056


                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      BASE                  1      34      69.09    <.0001
      trtn                  2      34       0.03    0.9683
      AVISITN               1      34       0.06    0.8060
      trtn*AVISITN          2      34       0.44    0.6447
      BASE*AVISITN          1      34       0.13    0.7159
      SSNRISN               1      34       2.31    0.1379
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=12 -------------------------

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      AVISITN*SSNRISN       1      34       0.86    0.3615


                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   1               4    -0.5103     0.2795     34
 trtn*AVISITN   1              12    -0.8014     0.2664     34
 trtn*AVISITN   2               4    -0.5003     0.2325     34
 trtn*AVISITN   2              12    -0.8229     0.2216     34
 trtn*AVISITN   3               4    -0.3307     0.2451     34
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=12 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   3              12    -0.8767     0.2337     34

                      Least Squares Means
 
                       Analysis
 Effect         trtn   Visit (N)    t Value   Pr > |t|    Alpha

 trtn*AVISITN   1               4     -1.83     0.0766     0.05
 trtn*AVISITN   1              12     -3.01     0.0049     0.05
 trtn*AVISITN   2               4     -2.15     0.0386     0.05
 trtn*AVISITN   2              12     -3.71     0.0007     0.05
 trtn*AVISITN   3               4     -1.35     0.1862     0.05
 trtn*AVISITN   3              12     -3.75     0.0007     0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=12 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                          Analysis
    Effect         trtn   Visit (N)       Lower       Upper

    trtn*AVISITN   1               4    -1.0783     0.05765
    trtn*AVISITN   1              12    -1.3427     -0.2600
    trtn*AVISITN   2               4    -0.9727    -0.02783
    trtn*AVISITN   2              12    -1.2732     -0.3726
    trtn*AVISITN   3               4    -0.8289      0.1675
    trtn*AVISITN   3              12    -1.3516     -0.4019


 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=12 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  1              4  1              12    0.2910
  trtn*AVISITN  1              4  2               4  -0.01007
  trtn*AVISITN  1              4  2              12    0.3126
  trtn*AVISITN  1              4  3               4   -0.1796
  trtn*AVISITN  1              4  3              12    0.3664
  trtn*AVISITN  1             12  2               4   -0.3011
  trtn*AVISITN  1             12  2              12   0.02152
  trtn*AVISITN  1             12  3               4   -0.4707
  trtn*AVISITN  1             12  3              12   0.07535
  trtn*AVISITN  2              4  2              12    0.3226
  trtn*AVISITN  2              4  3               4   -0.1696
  trtn*AVISITN  2              4  3              12    0.3765
  trtn*AVISITN  2             12  3               4   -0.4922
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=12 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  1              4  1              12    0.2701
  trtn*AVISITN  1              4  2               4    0.3272
  trtn*AVISITN  1              4  2              12    0.3391
  trtn*AVISITN  1              4  3               4    0.3312
  trtn*AVISITN  1              4  3              12    0.3447
  trtn*AVISITN  1             12  2               4    0.3358
  trtn*AVISITN  1             12  2              12    0.3118
  trtn*AVISITN  1             12  3               4    0.3423
  trtn*AVISITN  1             12  3              12    0.3157
  trtn*AVISITN  2              4  2              12    0.2247
  trtn*AVISITN  2              4  3               4    0.2863
  trtn*AVISITN  2              4  3              12    0.3049
  trtn*AVISITN  2             12  3               4    0.3058
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=12 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  1              4  1              12    34     1.08
trtn*AVISITN  1              4  2               4    34    -0.03
trtn*AVISITN  1              4  2              12  57.9     0.92
trtn*AVISITN  1              4  3               4    34    -0.54
trtn*AVISITN  1              4  3              12  59.3     1.06
trtn*AVISITN  1             12  2               4  59.5    -0.90
trtn*AVISITN  1             12  2              12    34     0.07
trtn*AVISITN  1             12  3               4  60.6    -1.37
trtn*AVISITN  1             12  3              12    34     0.24
trtn*AVISITN  2              4  2              12    34     1.44
trtn*AVISITN  2              4  3               4    34    -0.59
trtn*AVISITN  2              4  3              12  63.5     1.23
trtn*AVISITN  2             12  3               4  62.8    -1.61
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=12 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  1              4  1              12    0.2889
  trtn*AVISITN  1              4  2               4    0.9756
  trtn*AVISITN  1              4  2              12    0.3605
  trtn*AVISITN  1              4  3               4    0.5911
  trtn*AVISITN  1              4  3              12    0.2921
  trtn*AVISITN  1             12  2               4    0.3735
  trtn*AVISITN  1             12  2              12    0.9454
  trtn*AVISITN  1             12  3               4    0.1742
  trtn*AVISITN  1             12  3              12    0.8128
  trtn*AVISITN  2              4  2              12    0.1602
  trtn*AVISITN  2              4  3               4    0.5576
  trtn*AVISITN  2              4  3              12    0.2215
  trtn*AVISITN  2             12  3               4    0.1125
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=12 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  1              4  1              12    0.05
   trtn*AVISITN  1              4  2               4    0.05
   trtn*AVISITN  1              4  2              12    0.05
   trtn*AVISITN  1              4  3               4    0.05
   trtn*AVISITN  1              4  3              12    0.05
   trtn*AVISITN  1             12  2               4    0.05
   trtn*AVISITN  1             12  2              12    0.05
   trtn*AVISITN  1             12  3               4    0.05
   trtn*AVISITN  1             12  3              12    0.05
   trtn*AVISITN  2              4  2              12    0.05
   trtn*AVISITN  2              4  3               4    0.05
   trtn*AVISITN  2              4  3              12    0.05
   trtn*AVISITN  2             12  3               4    0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=12 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  1              4  1              12   -0.2580
  trtn*AVISITN  1              4  2               4   -0.6750
  trtn*AVISITN  1              4  2              12   -0.3662
  trtn*AVISITN  1              4  3               4   -0.8528
  trtn*AVISITN  1              4  3              12   -0.3233
  trtn*AVISITN  1             12  2               4   -0.9729
  trtn*AVISITN  1             12  2              12   -0.6122
  trtn*AVISITN  1             12  3               4   -1.1553
  trtn*AVISITN  1             12  3              12   -0.5663
  trtn*AVISITN  2              4  2              12   -0.1340
  trtn*AVISITN  2              4  3               4   -0.7514
  trtn*AVISITN  2              4  3              12   -0.2327
  trtn*AVISITN  2             12  3               4   -1.1033
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=12 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  1              4  1              12    0.8400
  trtn*AVISITN  1              4  2               4    0.6548
  trtn*AVISITN  1              4  2              12    0.9913
  trtn*AVISITN  1              4  3               4    0.4935
  trtn*AVISITN  1              4  3              12    1.0561
  trtn*AVISITN  1             12  2               4    0.3707
  trtn*AVISITN  1             12  2              12    0.6552
  trtn*AVISITN  1             12  3               4    0.2139
  trtn*AVISITN  1             12  3              12    0.7170
  trtn*AVISITN  2              4  2              12    0.7793
  trtn*AVISITN  2              4  3               4    0.4122
  trtn*AVISITN  2              4  3              12    0.9857
  trtn*AVISITN  2             12  3               4    0.1189
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=12 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  2             12  3              12   0.05383
  trtn*AVISITN  3              4  3              12    0.5460

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  2             12  3              12    0.2729
  trtn*AVISITN  3              4  3              12    0.2369

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=12 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  2             12  3              12    34     0.20
trtn*AVISITN  3              4  3              12    34     2.30

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  2             12  3              12    0.8448
  trtn*AVISITN  3              4  3              12    0.0274

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=12 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  2             12  3              12    0.05
   trtn*AVISITN  3              4  3              12    0.05

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  2             12  3              12   -0.5007
  trtn*AVISITN  3              4  3              12   0.06450

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=12 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  2             12  3              12    0.6084
  trtn*AVISITN  3              4  3              12    1.0276
 
 
 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=13 -------------------------

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.TARGET_1            
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=13 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             39    10631001 10631002 10631003    
                           11601002 11601006 11601007    
                           13031001 13031004 13581001    
                           13581010 13581014 13991001    
                           13991002 13991004 13991007    
                           13991009 13991010 16591001    
                           16591003 16591006 17601002    
                           17601003 17601005 17601007    
                           17601012 17601014 17601025    
                           17661002 17661004 17661006    
                           19691001 19731001 19731002    
                           19731004 19731006 19831001    
                           19831005 19831008 19901003    
      trtn            3    1 2 3                         
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=13 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      AVISITN         2    4 12                          
      SSNRISN         2    1 2                           


                          Dimensions

              Covariance Parameters             3
              Columns in X                     21
              Columns in Z                      0
              Subjects                         39
              Max Obs per Subject               2
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=13 -------------------------

                      The Mixed Procedure

                    Number of Observations

          Number of Observations Read              78
          Number of Observations Used              78
          Number of Observations Not Used           0


                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       199.73787889                
          1              1       194.66235597      0.00000000


                   Convergence criteria met.                    
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=13 -------------------------

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.6398
                UN(2,1)     id           0.2551
                UN(2,2)     id           0.9083


                        Fit Statistics

             -2 Res Log Likelihood           194.7
             AIC (Smaller is Better)         200.7
             AICC (Smaller is Better)        201.0
             BIC (Smaller is Better)         205.7
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=13 -------------------------

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   2          5.08          0.0790


                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      BASE                  1      34      64.13    <.0001
      trtn                  2      34       0.18    0.8371
      AVISITN               1      34       0.06    0.8142
      trtn*AVISITN          2      34       0.23    0.7969
      BASE*AVISITN          1      34       0.12    0.7331
      SSNRISN               1      34       2.06    0.1603
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=13 -------------------------

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      AVISITN*SSNRISN       1      34       0.65    0.4260


                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   1               4    -0.5056     0.2894     34
 trtn*AVISITN   1              12    -0.4789     0.3448     34
 trtn*AVISITN   2               4    -0.4956     0.2407     34
 trtn*AVISITN   2              12    -0.5083     0.2868     34
 trtn*AVISITN   3               4    -0.2409     0.2538     34
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=13 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   3              12    -0.4681     0.3024     34

                      Least Squares Means
 
                       Analysis
 Effect         trtn   Visit (N)    t Value   Pr > |t|    Alpha

 trtn*AVISITN   1               4     -1.75     0.0896     0.05
 trtn*AVISITN   1              12     -1.39     0.1739     0.05
 trtn*AVISITN   2               4     -2.06     0.0472     0.05
 trtn*AVISITN   2              12     -1.77     0.0853     0.05
 trtn*AVISITN   3               4     -0.95     0.3491     0.05
 trtn*AVISITN   3              12     -1.55     0.1308     0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=13 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                          Analysis
    Effect         trtn   Visit (N)       Lower       Upper

    trtn*AVISITN   1               4    -1.0936     0.08246
    trtn*AVISITN   1              12    -1.1795      0.2218
    trtn*AVISITN   2               4    -0.9847    -0.00652
    trtn*AVISITN   2              12    -1.0910     0.07448
    trtn*AVISITN   3               4    -0.7567      0.2748
    trtn*AVISITN   3              12    -1.0827      0.1464


 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=13 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  1              4  1              12  -0.02672
  trtn*AVISITN  1              4  2               4  -0.00996
  trtn*AVISITN  1              4  2              12  0.002699
  trtn*AVISITN  1              4  3               4   -0.2646
  trtn*AVISITN  1              4  3              12  -0.03744
  trtn*AVISITN  1             12  2               4   0.01676
  trtn*AVISITN  1             12  2              12   0.02942
  trtn*AVISITN  1             12  3               4   -0.2379
  trtn*AVISITN  1             12  3              12  -0.01072
  trtn*AVISITN  2              4  2              12   0.01266
  trtn*AVISITN  2              4  3               4   -0.2547
  trtn*AVISITN  2              4  3              12  -0.02748
  trtn*AVISITN  2             12  3               4   -0.2673
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=13 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  1              4  1              12    0.3685
  trtn*AVISITN  1              4  2               4    0.3387
  trtn*AVISITN  1              4  2              12    0.3940
  trtn*AVISITN  1              4  3               4    0.3429
  trtn*AVISITN  1              4  3              12    0.4037
  trtn*AVISITN  1             12  2               4    0.4075
  trtn*AVISITN  1             12  2              12    0.4036
  trtn*AVISITN  1             12  3               4    0.4136
  trtn*AVISITN  1             12  3              12    0.4086
  trtn*AVISITN  2              4  2              12    0.3065
  trtn*AVISITN  2              4  3               4    0.2964
  trtn*AVISITN  2              4  3              12    0.3683
  trtn*AVISITN  2             12  3               4    0.3645
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=13 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  1              4  1              12    34    -0.07
trtn*AVISITN  1              4  2               4    34    -0.03
trtn*AVISITN  1              4  2              12  66.5     0.01
trtn*AVISITN  1              4  3               4    34    -0.77
trtn*AVISITN  1              4  3              12  66.6    -0.09
trtn*AVISITN  1             12  2               4  59.3     0.04
trtn*AVISITN  1             12  2              12    34     0.07
trtn*AVISITN  1             12  3               4  61.2    -0.58
trtn*AVISITN  1             12  3              12    34    -0.03
trtn*AVISITN  2              4  2              12    34     0.04
trtn*AVISITN  2              4  3               4    34    -0.86
trtn*AVISITN  2              4  3              12  64.2    -0.07
trtn*AVISITN  2             12  3               4  66.7    -0.73
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=13 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  1              4  1              12    0.9426
  trtn*AVISITN  1              4  2               4    0.9767
  trtn*AVISITN  1              4  2              12    0.9946
  trtn*AVISITN  1              4  3               4    0.4456
  trtn*AVISITN  1              4  3              12    0.9264
  trtn*AVISITN  1             12  2               4    0.9673
  trtn*AVISITN  1             12  2              12    0.9423
  trtn*AVISITN  1             12  3               4    0.5673
  trtn*AVISITN  1             12  3              12    0.9792
  trtn*AVISITN  2              4  2              12    0.9673
  trtn*AVISITN  2              4  3               4    0.3962
  trtn*AVISITN  2              4  3              12    0.9407
  trtn*AVISITN  2             12  3               4    0.4659
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=13 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  1              4  1              12    0.05
   trtn*AVISITN  1              4  2               4    0.05
   trtn*AVISITN  1              4  2              12    0.05
   trtn*AVISITN  1              4  3               4    0.05
   trtn*AVISITN  1              4  3              12    0.05
   trtn*AVISITN  1             12  2               4    0.05
   trtn*AVISITN  1             12  2              12    0.05
   trtn*AVISITN  1             12  3               4    0.05
   trtn*AVISITN  1             12  3              12    0.05
   trtn*AVISITN  2              4  2              12    0.05
   trtn*AVISITN  2              4  3               4    0.05
   trtn*AVISITN  2              4  3              12    0.05
   trtn*AVISITN  2             12  3               4    0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=13 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  1              4  1              12   -0.7757
  trtn*AVISITN  1              4  2               4   -0.6983
  trtn*AVISITN  1              4  2              12   -0.7838
  trtn*AVISITN  1              4  3               4   -0.9616
  trtn*AVISITN  1              4  3              12   -0.8434
  trtn*AVISITN  1             12  2               4   -0.7985
  trtn*AVISITN  1             12  2              12   -0.7907
  trtn*AVISITN  1             12  3               4   -1.0650
  trtn*AVISITN  1             12  3              12   -0.8411
  trtn*AVISITN  2              4  2              12   -0.6103
  trtn*AVISITN  2              4  3               4   -0.8570
  trtn*AVISITN  2              4  3              12   -0.7631
  trtn*AVISITN  2             12  3               4   -0.9950
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=13 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  1              4  1              12    0.7223
  trtn*AVISITN  1              4  2               4    0.6784
  trtn*AVISITN  1              4  2              12    0.7892
  trtn*AVISITN  1              4  3               4    0.4323
  trtn*AVISITN  1              4  3              12    0.7685
  trtn*AVISITN  1             12  2               4    0.8321
  trtn*AVISITN  1             12  2              12    0.8496
  trtn*AVISITN  1             12  3               4    0.5891
  trtn*AVISITN  1             12  3              12    0.8197
  trtn*AVISITN  2              4  2              12    0.6356
  trtn*AVISITN  2              4  3               4    0.3477
  trtn*AVISITN  2              4  3              12    0.7081
  trtn*AVISITN  2             12  3               4    0.4604
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=13 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  2             12  3              12  -0.04014
  trtn*AVISITN  3              4  3              12    0.2272

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  2             12  3              12    0.3531
  trtn*AVISITN  3              4  3              12    0.3233

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=13 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  2             12  3              12    34    -0.11
trtn*AVISITN  3              4  3              12    34     0.70

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  2             12  3              12    0.9102
  trtn*AVISITN  3              4  3              12    0.4869

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=13 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  2             12  3              12    0.05
   trtn*AVISITN  3              4  3              12    0.05

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  2             12  3              12   -0.7578
  trtn*AVISITN  3              4  3              12   -0.4297

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=13 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  2             12  3              12    0.6775
  trtn*AVISITN  3              4  3              12    0.8841
 
 
 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=14 -------------------------

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.TARGET_1            
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=14 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             39    10631001 10631002 10631003    
                           11601002 11601006 11601007    
                           13031001 13031004 13581001    
                           13581010 13581014 13991001    
                           13991002 13991004 13991007    
                           13991009 13991010 16591001    
                           16591003 16591006 17601002    
                           17601003 17601005 17601007    
                           17601012 17601014 17601025    
                           17661002 17661004 17661006    
                           19691001 19731001 19731002    
                           19731004 19731006 19831001    
                           19831005 19831008 19901003    
      trtn            3    1 2 3                         
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=14 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      AVISITN         2    4 12                          
      SSNRISN         2    1 2                           


                          Dimensions

              Covariance Parameters             3
              Columns in X                     21
              Columns in Z                      0
              Subjects                         39
              Max Obs per Subject               2
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=14 -------------------------

                      The Mixed Procedure

                    Number of Observations

          Number of Observations Read              78
          Number of Observations Used              78
          Number of Observations Not Used           0


                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       246.40512113                
          1              1       230.67713907      0.00000000


                   Convergence criteria met.                    
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=14 -------------------------

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.6778
                UN(2,1)     id           0.3694
                UN(2,2)     id           2.3972


                        Fit Statistics

             -2 Res Log Likelihood           230.7
             AIC (Smaller is Better)         236.7
             AICC (Smaller is Better)        237.1
             BIC (Smaller is Better)         241.7
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=14 -------------------------

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   2         15.73          0.0004


                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      BASE                  1      34      38.61    <.0001
      trtn                  2      34       0.70    0.5054
      AVISITN               1      34       0.02    0.8854
      trtn*AVISITN          2      34       0.32    0.7314
      BASE*AVISITN          1      34       0.04    0.8430
      SSNRISN               1      34       0.54    0.4675
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=14 -------------------------

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      AVISITN*SSNRISN       1      34       0.02    0.8755


                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   1               4    -0.4550     0.2978     34
 trtn*AVISITN   1              12    -0.7134     0.5601     34
 trtn*AVISITN   2               4    -0.5293     0.2477     34
 trtn*AVISITN   2              12    -0.3088     0.4659     34
 trtn*AVISITN   3               4    -0.2122     0.2612     34
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=14 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   3              12   -0.02017     0.4913     34

                      Least Squares Means
 
                       Analysis
 Effect         trtn   Visit (N)    t Value   Pr > |t|    Alpha

 trtn*AVISITN   1               4     -1.53     0.1358     0.05
 trtn*AVISITN   1              12     -1.27     0.2114     0.05
 trtn*AVISITN   2               4     -2.14     0.0399     0.05
 trtn*AVISITN   2              12     -0.66     0.5119     0.05
 trtn*AVISITN   3               4     -0.81     0.4223     0.05
 trtn*AVISITN   3              12     -0.04     0.9675     0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=14 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                          Analysis
    Effect         trtn   Visit (N)       Lower       Upper

    trtn*AVISITN   1               4    -1.0603      0.1502
    trtn*AVISITN   1              12    -1.8516      0.4249
    trtn*AVISITN   2               4    -1.0327    -0.02584
    trtn*AVISITN   2              12    -1.2555      0.6380
    trtn*AVISITN   3               4    -0.7431      0.3187
    trtn*AVISITN   3              12    -1.0185      0.9782


 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=14 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  1              4  1              12    0.2583
  trtn*AVISITN  1              4  2               4   0.07424
  trtn*AVISITN  1              4  2              12   -0.1463
  trtn*AVISITN  1              4  3               4   -0.2429
  trtn*AVISITN  1              4  3              12   -0.4349
  trtn*AVISITN  1             12  2               4   -0.1841
  trtn*AVISITN  1             12  2              12   -0.4046
  trtn*AVISITN  1             12  3               4   -0.5012
  trtn*AVISITN  1             12  3              12   -0.6932
  trtn*AVISITN  2              4  2              12   -0.2205
  trtn*AVISITN  2              4  3               4   -0.3171
  trtn*AVISITN  2              4  3              12   -0.5091
  trtn*AVISITN  2             12  3               4  -0.09658
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=14 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  1              4  1              12    0.5529
  trtn*AVISITN  1              4  2               4    0.3486
  trtn*AVISITN  1              4  2              12    0.5387
  trtn*AVISITN  1              4  3               4    0.3530
  trtn*AVISITN  1              4  3              12    0.5589
  trtn*AVISITN  1             12  2               4    0.5996
  trtn*AVISITN  1             12  2              12    0.6556
  trtn*AVISITN  1             12  3               4    0.6036
  trtn*AVISITN  1             12  3              12    0.6638
  trtn*AVISITN  2              4  2              12    0.4599
  trtn*AVISITN  2              4  3               4    0.3051
  trtn*AVISITN  2              4  3              12    0.5318
  trtn*AVISITN  2             12  3               4    0.5151
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=14 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  1              4  1              12    34     0.47
trtn*AVISITN  1              4  2               4    34     0.21
trtn*AVISITN  1              4  2              12    57    -0.27
trtn*AVISITN  1              4  3               4    34    -0.69
trtn*AVISITN  1              4  3              12  55.2    -0.78
trtn*AVISITN  1             12  2               4  46.1    -0.31
trtn*AVISITN  1             12  2              12    34    -0.62
trtn*AVISITN  1             12  3               4  47.4    -0.83
trtn*AVISITN  1             12  3              12    34    -1.04
trtn*AVISITN  2              4  2              12    34    -0.48
trtn*AVISITN  2              4  3               4    34    -1.04
trtn*AVISITN  2              4  3              12  49.4    -0.96
trtn*AVISITN  2             12  3               4  52.7    -0.19
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=14 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  1              4  1              12    0.6433
  trtn*AVISITN  1              4  2               4    0.8326
  trtn*AVISITN  1              4  2              12    0.7870
  trtn*AVISITN  1              4  3               4    0.4961
  trtn*AVISITN  1              4  3              12    0.4399
  trtn*AVISITN  1             12  2               4    0.7602
  trtn*AVISITN  1             12  2              12    0.5413
  trtn*AVISITN  1             12  3               4    0.4105
  trtn*AVISITN  1             12  3              12    0.3037
  trtn*AVISITN  2              4  2              12    0.6347
  trtn*AVISITN  2              4  3               4    0.3060
  trtn*AVISITN  2              4  3              12    0.3430
  trtn*AVISITN  2             12  3               4    0.8520
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=14 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  1              4  1              12    0.05
   trtn*AVISITN  1              4  2               4    0.05
   trtn*AVISITN  1              4  2              12    0.05
   trtn*AVISITN  1              4  3               4    0.05
   trtn*AVISITN  1              4  3              12    0.05
   trtn*AVISITN  1             12  2               4    0.05
   trtn*AVISITN  1             12  2              12    0.05
   trtn*AVISITN  1             12  3               4    0.05
   trtn*AVISITN  1             12  3              12    0.05
   trtn*AVISITN  2              4  2              12    0.05
   trtn*AVISITN  2              4  3               4    0.05
   trtn*AVISITN  2              4  3              12    0.05
   trtn*AVISITN  2             12  3               4    0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=14 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  1              4  1              12   -0.8653
  trtn*AVISITN  1              4  2               4   -0.6343
  trtn*AVISITN  1              4  2              12   -1.2250
  trtn*AVISITN  1              4  3               4   -0.9602
  trtn*AVISITN  1              4  3              12   -1.5549
  trtn*AVISITN  1             12  2               4   -1.3910
  trtn*AVISITN  1             12  2              12   -1.7370
  trtn*AVISITN  1             12  3               4   -1.7152
  trtn*AVISITN  1             12  3              12   -2.0422
  trtn*AVISITN  2              4  2              12   -1.1551
  trtn*AVISITN  2              4  3               4   -0.9371
  trtn*AVISITN  2              4  3              12   -1.5775
  trtn*AVISITN  2             12  3               4   -1.1299
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=14 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  1              4  1              12    1.3820
  trtn*AVISITN  1              4  2               4    0.7828
  trtn*AVISITN  1              4  2              12    0.9324
  trtn*AVISITN  1              4  3               4    0.4745
  trtn*AVISITN  1              4  3              12    0.6852
  trtn*AVISITN  1             12  2               4    1.0227
  trtn*AVISITN  1             12  2              12    0.9278
  trtn*AVISITN  1             12  3               4    0.7128
  trtn*AVISITN  1             12  3              12    0.6558
  trtn*AVISITN  2              4  2              12    0.7141
  trtn*AVISITN  2              4  3               4    0.3029
  trtn*AVISITN  2              4  3              12    0.5593
  trtn*AVISITN  2             12  3               4    0.9368
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=14 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  2             12  3              12   -0.2886
  trtn*AVISITN  3              4  3              12   -0.1920

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  2             12  3              12    0.5737
  trtn*AVISITN  3              4  3              12    0.4850

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=14 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  2             12  3              12    34    -0.50
trtn*AVISITN  3              4  3              12    34    -0.40

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  2             12  3              12    0.6182
  trtn*AVISITN  3              4  3              12    0.6946

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=14 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  2             12  3              12    0.05
   trtn*AVISITN  3              4  3              12    0.05

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  2             12  3              12   -1.4545
  trtn*AVISITN  3              4  3              12   -1.1776

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=14 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  2             12  3              12    0.8773
  trtn*AVISITN  3              4  3              12    0.7936
 
 
 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=15 -------------------------

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.TARGET_1            
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=15 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             39    10631001 10631002 10631003    
                           11601002 11601006 11601007    
                           13031001 13031004 13581001    
                           13581010 13581014 13991001    
                           13991002 13991004 13991007    
                           13991009 13991010 16591001    
                           16591003 16591006 17601002    
                           17601003 17601005 17601007    
                           17601012 17601014 17601025    
                           17661002 17661004 17661006    
                           19691001 19731001 19731002    
                           19731004 19731006 19831001    
                           19831005 19831008 19901003    
      trtn            3    1 2 3                         
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=15 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      AVISITN         2    4 12                          
      SSNRISN         2    1 2                           


                          Dimensions

              Covariance Parameters             3
              Columns in X                     21
              Columns in Z                      0
              Subjects                         39
              Max Obs per Subject               2
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=15 -------------------------

                      The Mixed Procedure

                    Number of Observations

          Number of Observations Read              78
          Number of Observations Used              78
          Number of Observations Not Used           0


                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       208.27816727                
          1              1       192.43272492      0.00000000


                   Convergence criteria met.                    
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=15 -------------------------

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.6350
                UN(2,1)     id           0.4775
                UN(2,2)     id           1.1203


                        Fit Statistics

             -2 Res Log Likelihood           192.4
             AIC (Smaller is Better)         198.4
             AICC (Smaller is Better)        198.8
             BIC (Smaller is Better)         203.4
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=15 -------------------------

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   2         15.85          0.0004


                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      BASE                  1      34      46.16    <.0001
      trtn                  2      34       0.18    0.8339
      AVISITN               1      34       3.90    0.0565
      trtn*AVISITN          2      34       0.80    0.4559
      BASE*AVISITN          1      34       1.13    0.2955
      SSNRISN               1      34       2.55    0.1194
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=15 -------------------------

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      AVISITN*SSNRISN       1      34       0.38    0.5438


                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   1               4    -0.4344     0.2883     34
 trtn*AVISITN   1              12    -1.1251     0.3829     34
 trtn*AVISITN   2               4    -0.4987     0.2398     34
 trtn*AVISITN   2              12    -1.1426     0.3185     34
 trtn*AVISITN   3               4    -0.4493     0.2528     34
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=15 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   3              12    -1.4895     0.3358     34

                      Least Squares Means
 
                       Analysis
 Effect         trtn   Visit (N)    t Value   Pr > |t|    Alpha

 trtn*AVISITN   1               4     -1.51     0.1410     0.05
 trtn*AVISITN   1              12     -2.94     0.0059     0.05
 trtn*AVISITN   2               4     -2.08     0.0451     0.05
 trtn*AVISITN   2              12     -3.59     0.0010     0.05
 trtn*AVISITN   3               4     -1.78     0.0845     0.05
 trtn*AVISITN   3              12     -4.44     <.0001     0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=15 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                          Analysis
    Effect         trtn   Visit (N)       Lower       Upper

    trtn*AVISITN   1               4    -1.0202      0.1514
    trtn*AVISITN   1              12    -1.9032     -0.3470
    trtn*AVISITN   2               4    -0.9860    -0.01147
    trtn*AVISITN   2              12    -1.7898     -0.4954
    trtn*AVISITN   3               4    -0.9631     0.06456
    trtn*AVISITN   3              12    -2.1720     -0.8070


 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=15 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  1              4  1              12    0.6907
  trtn*AVISITN  1              4  2               4   0.06432
  trtn*AVISITN  1              4  2              12    0.7082
  trtn*AVISITN  1              4  3               4   0.01485
  trtn*AVISITN  1              4  3              12    1.0551
  trtn*AVISITN  1             12  2               4   -0.6263
  trtn*AVISITN  1             12  2              12   0.01755
  trtn*AVISITN  1             12  3               4   -0.6758
  trtn*AVISITN  1             12  3              12    0.3644
  trtn*AVISITN  2              4  2              12    0.6439
  trtn*AVISITN  2              4  3               4  -0.04946
  trtn*AVISITN  2              4  3              12    0.9908
  trtn*AVISITN  2             12  3               4   -0.6933
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=15 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  1              4  1              12    0.3236
  trtn*AVISITN  1              4  2               4    0.3374
  trtn*AVISITN  1              4  2              12    0.4055
  trtn*AVISITN  1              4  3               4    0.3416
  trtn*AVISITN  1              4  3              12    0.4160
  trtn*AVISITN  1             12  2               4    0.4289
  trtn*AVISITN  1             12  2              12    0.4482
  trtn*AVISITN  1             12  3               4    0.4333
  trtn*AVISITN  1             12  3              12    0.4538
  trtn*AVISITN  2              4  2              12    0.2691
  trtn*AVISITN  2              4  3               4    0.2953
  trtn*AVISITN  2              4  3              12    0.3802
  trtn*AVISITN  2             12  3               4    0.3736
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=15 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  1              4  1              12    34     2.13
trtn*AVISITN  1              4  2               4    34     0.19
trtn*AVISITN  1              4  2              12  57.4     1.75
trtn*AVISITN  1              4  3               4    34     0.04
trtn*AVISITN  1              4  3              12  57.3     2.54
trtn*AVISITN  1             12  2               4  50.4    -1.46
trtn*AVISITN  1             12  2              12    34     0.04
trtn*AVISITN  1             12  3               4    52    -1.56
trtn*AVISITN  1             12  3              12    34     0.80
trtn*AVISITN  2              4  2              12    34     2.39
trtn*AVISITN  2              4  3               4    34    -0.17
trtn*AVISITN  2              4  3              12  55.6     2.61
trtn*AVISITN  2             12  3               4  58.2    -1.86
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=15 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  1              4  1              12    0.0401
  trtn*AVISITN  1              4  2               4    0.8500
  trtn*AVISITN  1              4  2              12    0.0861
  trtn*AVISITN  1              4  3               4    0.9656
  trtn*AVISITN  1              4  3              12    0.0140
  trtn*AVISITN  1             12  2               4    0.1504
  trtn*AVISITN  1             12  2              12    0.9690
  trtn*AVISITN  1             12  3               4    0.1249
  trtn*AVISITN  1             12  3              12    0.4275
  trtn*AVISITN  2              4  2              12    0.0224
  trtn*AVISITN  2              4  3               4    0.8680
  trtn*AVISITN  2              4  3              12    0.0117
  trtn*AVISITN  2             12  3               4    0.0686
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=15 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  1              4  1              12    0.05
   trtn*AVISITN  1              4  2               4    0.05
   trtn*AVISITN  1              4  2              12    0.05
   trtn*AVISITN  1              4  3               4    0.05
   trtn*AVISITN  1              4  3              12    0.05
   trtn*AVISITN  1             12  2               4    0.05
   trtn*AVISITN  1             12  2              12    0.05
   trtn*AVISITN  1             12  3               4    0.05
   trtn*AVISITN  1             12  3              12    0.05
   trtn*AVISITN  2              4  2              12    0.05
   trtn*AVISITN  2              4  3               4    0.05
   trtn*AVISITN  2              4  3              12    0.05
   trtn*AVISITN  2             12  3               4    0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=15 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  1              4  1              12   0.03304
  trtn*AVISITN  1              4  2               4   -0.6214
  trtn*AVISITN  1              4  2              12   -0.1037
  trtn*AVISITN  1              4  3               4   -0.6794
  trtn*AVISITN  1              4  3              12    0.2221
  trtn*AVISITN  1             12  2               4   -1.4877
  trtn*AVISITN  1             12  2              12   -0.8933
  trtn*AVISITN  1             12  3               4   -1.5453
  trtn*AVISITN  1             12  3              12   -0.5578
  trtn*AVISITN  2              4  2              12   0.09691
  trtn*AVISITN  2              4  3               4   -0.6495
  trtn*AVISITN  2              4  3              12    0.2290
  trtn*AVISITN  2             12  3               4   -1.4412
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=15 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  1              4  1              12    1.3483
  trtn*AVISITN  1              4  2               4    0.7501
  trtn*AVISITN  1              4  2              12    1.5201
  trtn*AVISITN  1              4  3               4    0.7091
  trtn*AVISITN  1              4  3              12    1.8881
  trtn*AVISITN  1             12  2               4    0.2350
  trtn*AVISITN  1             12  2              12    0.9284
  trtn*AVISITN  1             12  3               4    0.1937
  trtn*AVISITN  1             12  3              12    1.2866
  trtn*AVISITN  2              4  2              12    1.1909
  trtn*AVISITN  2              4  3               4    0.5506
  trtn*AVISITN  2              4  3              12    1.7525
  trtn*AVISITN  2             12  3               4   0.05452
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=15 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  2             12  3              12    0.3469
  trtn*AVISITN  3              4  3              12    1.0402

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  2             12  3              12    0.3922
  trtn*AVISITN  3              4  3              12    0.2838

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=15 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  2             12  3              12    34     0.88
trtn*AVISITN  3              4  3              12    34     3.67

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  2             12  3              12    0.3827
  trtn*AVISITN  3              4  3              12    0.0008

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=15 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  2             12  3              12    0.05
   trtn*AVISITN  3              4  3              12    0.05

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  2             12  3              12   -0.4502
  trtn*AVISITN  3              4  3              12    0.4634

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=15 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  2             12  3              12    1.1439
  trtn*AVISITN  3              4  3              12    1.6170
 
 
 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=16 -------------------------

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.TARGET_1            
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=16 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             39    10631001 10631002 10631003    
                           11601002 11601006 11601007    
                           13031001 13031004 13581001    
                           13581010 13581014 13991001    
                           13991002 13991004 13991007    
                           13991009 13991010 16591001    
                           16591003 16591006 17601002    
                           17601003 17601005 17601007    
                           17601012 17601014 17601025    
                           17661002 17661004 17661006    
                           19691001 19731001 19731002    
                           19731004 19731006 19831001    
                           19831005 19831008 19901003    
      trtn            3    1 2 3                         
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=16 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      AVISITN         2    4 12                          
      SSNRISN         2    1 2                           


                          Dimensions

              Covariance Parameters             3
              Columns in X                     21
              Columns in Z                      0
              Subjects                         39
              Max Obs per Subject               2
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=16 -------------------------

                      The Mixed Procedure

                    Number of Observations

          Number of Observations Read              78
          Number of Observations Used              78
          Number of Observations Not Used           0


                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       205.80279197                
          1              1       195.57776008      0.00000000


                   Convergence criteria met.                    
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=16 -------------------------

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.5398
                UN(2,1)     id           0.3034
                UN(2,2)     id           1.1527


                        Fit Statistics

             -2 Res Log Likelihood           195.6
             AIC (Smaller is Better)         201.6
             AICC (Smaller is Better)        202.0
             BIC (Smaller is Better)         206.6
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=16 -------------------------

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   2         10.23          0.0060


                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      BASE                  1      34      55.03    <.0001
      trtn                  2      34       0.39    0.6772
      AVISITN               1      34       0.01    0.9333
      trtn*AVISITN          2      34       0.08    0.9193
      BASE*AVISITN          1      34       0.00    0.9602
      SSNRISN               1      34       3.08    0.0884
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=16 -------------------------

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      AVISITN*SSNRISN       1      34       1.68    0.2037


                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   1               4    -0.4982     0.2658     34
 trtn*AVISITN   1              12    -0.6329     0.3884     34
 trtn*AVISITN   2               4    -0.4347     0.2211     34
 trtn*AVISITN   2              12    -0.4546     0.3230     34
 trtn*AVISITN   3               4    -0.3091     0.2331     34
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=16 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   3              12    -0.2603     0.3407     34

                      Least Squares Means
 
                       Analysis
 Effect         trtn   Visit (N)    t Value   Pr > |t|    Alpha

 trtn*AVISITN   1               4     -1.87     0.0695     0.05
 trtn*AVISITN   1              12     -1.63     0.1124     0.05
 trtn*AVISITN   2               4     -1.97     0.0575     0.05
 trtn*AVISITN   2              12     -1.41     0.1685     0.05
 trtn*AVISITN   3               4     -1.33     0.1936     0.05
 trtn*AVISITN   3              12     -0.76     0.4501     0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=16 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                          Analysis
    Effect         trtn   Visit (N)       Lower       Upper

    trtn*AVISITN   1               4    -1.0384     0.04189
    trtn*AVISITN   1              12    -1.4222      0.1564
    trtn*AVISITN   2               4    -0.8840     0.01454
    trtn*AVISITN   2              12    -1.1111      0.2019
    trtn*AVISITN   3               4    -0.7829      0.1646
    trtn*AVISITN   3              12    -0.9526      0.4320


 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=16 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  1              4  1              12    0.1347
  trtn*AVISITN  1              4  2               4  -0.06352
  trtn*AVISITN  1              4  2              12  -0.04365
  trtn*AVISITN  1              4  3               4   -0.1891
  trtn*AVISITN  1              4  3              12   -0.2379
  trtn*AVISITN  1             12  2               4   -0.1982
  trtn*AVISITN  1             12  2              12   -0.1783
  trtn*AVISITN  1             12  3               4   -0.3238
  trtn*AVISITN  1             12  3              12   -0.3726
  trtn*AVISITN  2              4  2              12   0.01988
  trtn*AVISITN  2              4  3               4   -0.1256
  trtn*AVISITN  2              4  3              12   -0.1744
  trtn*AVISITN  2             12  3               4   -0.1454
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=16 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  1              4  1              12    0.3769
  trtn*AVISITN  1              4  2               4    0.3111
  trtn*AVISITN  1              4  2              12    0.4028
  trtn*AVISITN  1              4  3               4    0.3150
  trtn*AVISITN  1              4  3              12    0.4150
  trtn*AVISITN  1             12  2               4    0.4324
  trtn*AVISITN  1             12  2              12    0.4546
  trtn*AVISITN  1             12  3               4    0.4367
  trtn*AVISITN  1             12  3              12    0.4603
  trtn*AVISITN  2              4  2              12    0.3135
  trtn*AVISITN  2              4  3               4    0.2722
  trtn*AVISITN  2              4  3              12    0.3854
  trtn*AVISITN  2             12  3               4    0.3773
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=16 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  1              4  1              12    34     0.36
trtn*AVISITN  1              4  2               4    34    -0.20
trtn*AVISITN  1              4  2              12  62.9    -0.11
trtn*AVISITN  1              4  3               4    34    -0.60
trtn*AVISITN  1              4  3              12  61.9    -0.57
trtn*AVISITN  1             12  2               4    52    -0.46
trtn*AVISITN  1             12  2              12    34    -0.39
trtn*AVISITN  1             12  3               4  53.8    -0.74
trtn*AVISITN  1             12  3              12    34    -0.81
trtn*AVISITN  2              4  2              12    34     0.06
trtn*AVISITN  2              4  3               4    34    -0.46
trtn*AVISITN  2              4  3              12  56.9    -0.45
trtn*AVISITN  2             12  3               4  60.6    -0.39
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=16 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  1              4  1              12    0.7231
  trtn*AVISITN  1              4  2               4    0.8394
  trtn*AVISITN  1              4  2              12    0.9140
  trtn*AVISITN  1              4  3               4    0.5523
  trtn*AVISITN  1              4  3              12    0.5685
  trtn*AVISITN  1             12  2               4    0.6486
  trtn*AVISITN  1             12  2              12    0.6974
  trtn*AVISITN  1             12  3               4    0.4617
  trtn*AVISITN  1             12  3              12    0.4239
  trtn*AVISITN  2              4  2              12    0.9498
  trtn*AVISITN  2              4  3               4    0.6476
  trtn*AVISITN  2              4  3              12    0.6526
  trtn*AVISITN  2             12  3               4    0.7012
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=16 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  1              4  1              12    0.05
   trtn*AVISITN  1              4  2               4    0.05
   trtn*AVISITN  1              4  2              12    0.05
   trtn*AVISITN  1              4  3               4    0.05
   trtn*AVISITN  1              4  3              12    0.05
   trtn*AVISITN  1             12  2               4    0.05
   trtn*AVISITN  1             12  2              12    0.05
   trtn*AVISITN  1             12  3               4    0.05
   trtn*AVISITN  1             12  3              12    0.05
   trtn*AVISITN  2              4  2              12    0.05
   trtn*AVISITN  2              4  3               4    0.05
   trtn*AVISITN  2              4  3              12    0.05
   trtn*AVISITN  2             12  3               4    0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=16 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  1              4  1              12   -0.6313
  trtn*AVISITN  1              4  2               4   -0.6958
  trtn*AVISITN  1              4  2              12   -0.8486
  trtn*AVISITN  1              4  3               4   -0.8292
  trtn*AVISITN  1              4  3              12   -1.0675
  trtn*AVISITN  1             12  2               4   -1.0658
  trtn*AVISITN  1             12  2              12   -1.1023
  trtn*AVISITN  1             12  3               4   -1.1994
  trtn*AVISITN  1             12  3              12   -1.3080
  trtn*AVISITN  2              4  2              12   -0.6172
  trtn*AVISITN  2              4  3               4   -0.6788
  trtn*AVISITN  2              4  3              12   -0.9462
  trtn*AVISITN  2             12  3               4   -0.9000
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=16 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  1              4  1              12    0.9006
  trtn*AVISITN  1              4  2               4    0.5687
  trtn*AVISITN  1              4  2              12    0.7613
  trtn*AVISITN  1              4  3               4    0.4510
  trtn*AVISITN  1              4  3              12    0.5916
  trtn*AVISITN  1             12  2               4    0.6694
  trtn*AVISITN  1             12  2              12    0.7456
  trtn*AVISITN  1             12  3               4    0.5519
  trtn*AVISITN  1             12  3              12    0.5629
  trtn*AVISITN  2              4  2              12    0.6570
  trtn*AVISITN  2              4  3               4    0.4277
  trtn*AVISITN  2              4  3              12    0.5974
  trtn*AVISITN  2             12  3               4    0.6091
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=16 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  2             12  3              12   -0.1943
  trtn*AVISITN  3              4  3              12  -0.04883

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  2             12  3              12    0.3978
  trtn*AVISITN  3              4  3              12    0.3306

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=16 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  2             12  3              12    34    -0.49
trtn*AVISITN  3              4  3              12    34    -0.15

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  2             12  3              12    0.6285
  trtn*AVISITN  3              4  3              12    0.8834

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=16 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  2             12  3              12    0.05
   trtn*AVISITN  3              4  3              12    0.05

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  2             12  3              12   -1.0028
  trtn*AVISITN  3              4  3              12   -0.7207

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=16 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  2             12  3              12    0.6142
  trtn*AVISITN  3              4  3              12    0.6230
 
 
 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=17 -------------------------

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.TARGET_1            
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=17 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             39    10631001 10631002 10631003    
                           11601002 11601006 11601007    
                           13031001 13031004 13581001    
                           13581010 13581014 13991001    
                           13991002 13991004 13991007    
                           13991009 13991010 16591001    
                           16591003 16591006 17601002    
                           17601003 17601005 17601007    
                           17601012 17601014 17601025    
                           17661002 17661004 17661006    
                           19691001 19731001 19731002    
                           19731004 19731006 19831001    
                           19831005 19831008 19901003    
      trtn            3    1 2 3                         
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=17 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      AVISITN         2    4 12                          
      SSNRISN         2    1 2                           


                          Dimensions

              Covariance Parameters             3
              Columns in X                     21
              Columns in Z                      0
              Subjects                         39
              Max Obs per Subject               2
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=17 -------------------------

                      The Mixed Procedure

                    Number of Observations

          Number of Observations Read              78
          Number of Observations Used              78
          Number of Observations Not Used           0


                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       181.25760423                
          1              1       171.56823915      0.00000000


                   Convergence criteria met.                    
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=17 -------------------------

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.5740
                UN(2,1)     id           0.2933
                UN(2,2)     id           0.6057


                        Fit Statistics

             -2 Res Log Likelihood           171.6
             AIC (Smaller is Better)         177.6
             AICC (Smaller is Better)        177.9
             BIC (Smaller is Better)         182.6
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=17 -------------------------

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   2          9.69          0.0079


                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      BASE                  1      34      67.12    <.0001
      trtn                  2      34       0.07    0.9345
      AVISITN               1      34       0.04    0.8525
      trtn*AVISITN          2      34       0.93    0.4062
      BASE*AVISITN          1      34       0.16    0.6960
      SSNRISN               1      34       3.43    0.0725
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=17 -------------------------

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      AVISITN*SSNRISN       1      34       1.45    0.2361


                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   1               4    -0.4963     0.2741     34
 trtn*AVISITN   1              12    -0.8197     0.2815     34
 trtn*AVISITN   2               4    -0.5162     0.2280     34
 trtn*AVISITN   2              12    -0.7252     0.2342     34
 trtn*AVISITN   3               4    -0.4156     0.2404     34
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=17 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   3              12    -1.0068     0.2469     34

                      Least Squares Means
 
                       Analysis
 Effect         trtn   Visit (N)    t Value   Pr > |t|    Alpha

 trtn*AVISITN   1               4     -1.81     0.0790     0.05
 trtn*AVISITN   1              12     -2.91     0.0063     0.05
 trtn*AVISITN   2               4     -2.26     0.0300     0.05
 trtn*AVISITN   2              12     -3.10     0.0039     0.05
 trtn*AVISITN   3               4     -1.73     0.0929     0.05
 trtn*AVISITN   3              12     -4.08     0.0003     0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=17 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                          Analysis
    Effect         trtn   Visit (N)       Lower       Upper

    trtn*AVISITN   1               4    -1.0533     0.06071
    trtn*AVISITN   1              12    -1.3919     -0.2476
    trtn*AVISITN   2               4    -0.9795    -0.05291
    trtn*AVISITN   2              12    -1.2011     -0.2493
    trtn*AVISITN   3               4    -0.9042     0.07291
    trtn*AVISITN   3              12    -1.5087     -0.5050


 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=17 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  1              4  1              12    0.3234
  trtn*AVISITN  1              4  2               4   0.01991
  trtn*AVISITN  1              4  2              12    0.2290
  trtn*AVISITN  1              4  3               4  -0.08065
  trtn*AVISITN  1              4  3              12    0.5106
  trtn*AVISITN  1             12  2               4   -0.3035
  trtn*AVISITN  1             12  2              12  -0.09448
  trtn*AVISITN  1             12  3               4   -0.4041
  trtn*AVISITN  1             12  3              12    0.1871
  trtn*AVISITN  2              4  2              12    0.2090
  trtn*AVISITN  2              4  3               4   -0.1006
  trtn*AVISITN  2              4  3              12    0.4906
  trtn*AVISITN  2             12  3               4   -0.3096
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=17 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  1              4  1              12    0.2786
  trtn*AVISITN  1              4  2               4    0.3208
  trtn*AVISITN  1              4  2              12    0.3429
  trtn*AVISITN  1              4  3               4    0.3248
  trtn*AVISITN  1              4  3              12    0.3494
  trtn*AVISITN  1             12  2               4    0.3448
  trtn*AVISITN  1             12  2              12    0.3296
  trtn*AVISITN  1             12  3               4    0.3508
  trtn*AVISITN  1             12  3              12    0.3337
  trtn*AVISITN  2              4  2              12    0.2317
  trtn*AVISITN  2              4  3               4    0.2807
  trtn*AVISITN  2              4  3              12    0.3117
  trtn*AVISITN  2             12  3               4    0.3111
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=17 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  1              4  1              12    34     1.16
trtn*AVISITN  1              4  2               4    34     0.06
trtn*AVISITN  1              4  2              12  59.8     0.67
trtn*AVISITN  1              4  3               4    34    -0.25
trtn*AVISITN  1              4  3              12    61     1.46
trtn*AVISITN  1             12  2               4  58.8    -0.88
trtn*AVISITN  1             12  2              12    34    -0.29
trtn*AVISITN  1             12  3               4  60.2    -1.15
trtn*AVISITN  1             12  3              12    34     0.56
trtn*AVISITN  2              4  2              12    34     0.90
trtn*AVISITN  2              4  3               4    34    -0.36
trtn*AVISITN  2              4  3              12  63.6     1.57
trtn*AVISITN  2             12  3               4  63.9    -1.00
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=17 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  1              4  1              12    0.2537
  trtn*AVISITN  1              4  2               4    0.9509
  trtn*AVISITN  1              4  2              12    0.5069
  trtn*AVISITN  1              4  3               4    0.8054
  trtn*AVISITN  1              4  3              12    0.1491
  trtn*AVISITN  1             12  2               4    0.3823
  trtn*AVISITN  1             12  2              12    0.7761
  trtn*AVISITN  1             12  3               4    0.2539
  trtn*AVISITN  1             12  3              12    0.5786
  trtn*AVISITN  2              4  2              12    0.3733
  trtn*AVISITN  2              4  3               4    0.7224
  trtn*AVISITN  2              4  3              12    0.1204
  trtn*AVISITN  2             12  3               4    0.3235
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=17 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  1              4  1              12    0.05
   trtn*AVISITN  1              4  2               4    0.05
   trtn*AVISITN  1              4  2              12    0.05
   trtn*AVISITN  1              4  3               4    0.05
   trtn*AVISITN  1              4  3              12    0.05
   trtn*AVISITN  1             12  2               4    0.05
   trtn*AVISITN  1             12  2              12    0.05
   trtn*AVISITN  1             12  3               4    0.05
   trtn*AVISITN  1             12  3              12    0.05
   trtn*AVISITN  2              4  2              12    0.05
   trtn*AVISITN  2              4  3               4    0.05
   trtn*AVISITN  2              4  3              12    0.05
   trtn*AVISITN  2             12  3               4    0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=17 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  1              4  1              12   -0.2427
  trtn*AVISITN  1              4  2               4   -0.6321
  trtn*AVISITN  1              4  2              12   -0.4571
  trtn*AVISITN  1              4  3               4   -0.7408
  trtn*AVISITN  1              4  3              12   -0.1882
  trtn*AVISITN  1             12  2               4   -0.9935
  trtn*AVISITN  1             12  2              12   -0.7642
  trtn*AVISITN  1             12  3               4   -1.1057
  trtn*AVISITN  1             12  3              12   -0.4910
  trtn*AVISITN  2              4  2              12   -0.2619
  trtn*AVISITN  2              4  3               4   -0.6711
  trtn*AVISITN  2              4  3              12   -0.1321
  trtn*AVISITN  2             12  3               4   -0.9312
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=17 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  1              4  1              12    0.8896
  trtn*AVISITN  1              4  2               4    0.6719
  trtn*AVISITN  1              4  2              12    0.9150
  trtn*AVISITN  1              4  3               4    0.5795
  trtn*AVISITN  1              4  3              12    1.2093
  trtn*AVISITN  1             12  2               4    0.3865
  trtn*AVISITN  1             12  2              12    0.5753
  trtn*AVISITN  1             12  3               4    0.2975
  trtn*AVISITN  1             12  3              12    0.8652
  trtn*AVISITN  2              4  2              12    0.6800
  trtn*AVISITN  2              4  3               4    0.4700
  trtn*AVISITN  2              4  3              12    1.1133
  trtn*AVISITN  2             12  3               4    0.3120
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=17 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  2             12  3              12    0.2816
  trtn*AVISITN  3              4  3              12    0.5912

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  2             12  3              12    0.2884
  trtn*AVISITN  3              4  3              12    0.2444

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=17 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  2             12  3              12    34     0.98
trtn*AVISITN  3              4  3              12    34     2.42

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  2             12  3              12    0.3357
  trtn*AVISITN  3              4  3              12    0.0210

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=17 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  2             12  3              12    0.05
   trtn*AVISITN  3              4  3              12    0.05

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  2             12  3              12   -0.3045
  trtn*AVISITN  3              4  3              12   0.09462

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=17 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  2             12  3              12    0.8677
  trtn*AVISITN  3              4  3              12    1.0878
 
 
 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=18 -------------------------

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.TARGET_1            
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=18 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             39    10631001 10631002 10631003    
                           11601002 11601006 11601007    
                           13031001 13031004 13581001    
                           13581010 13581014 13991001    
                           13991002 13991004 13991007    
                           13991009 13991010 16591001    
                           16591003 16591006 17601002    
                           17601003 17601005 17601007    
                           17601012 17601014 17601025    
                           17661002 17661004 17661006    
                           19691001 19731001 19731002    
                           19731004 19731006 19831001    
                           19831005 19831008 19901003    
      trtn            3    1 2 3                         
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=18 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      AVISITN         2    4 12                          
      SSNRISN         2    1 2                           


                          Dimensions

              Covariance Parameters             3
              Columns in X                     21
              Columns in Z                      0
              Subjects                         39
              Max Obs per Subject               2
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=18 -------------------------

                      The Mixed Procedure

                    Number of Observations

          Number of Observations Read              78
          Number of Observations Used              78
          Number of Observations Not Used           0


                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       193.19232374                
          1              1       188.81013806      0.00000000


                   Convergence criteria met.                    
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=18 -------------------------

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.6868
                UN(2,1)     id           0.2439
                UN(2,2)     id           0.7192


                        Fit Statistics

             -2 Res Log Likelihood           188.8
             AIC (Smaller is Better)         194.8
             AICC (Smaller is Better)        195.2
             BIC (Smaller is Better)         199.8
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=18 -------------------------

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   2          4.38          0.1118


                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      BASE                  1      34      52.71    <.0001
      trtn                  2      34       0.30    0.7437
      AVISITN               1      34       0.76    0.3882
      trtn*AVISITN          2      34       0.10    0.9011
      BASE*AVISITN          1      34       0.57    0.4550
      SSNRISN               1      34       2.96    0.0943
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=18 -------------------------

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      AVISITN*SSNRISN       1      34       0.74    0.3962


                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   1               4    -0.4933     0.2998     34
 trtn*AVISITN   1              12    -0.7566     0.3068     34
 trtn*AVISITN   2               4    -0.5333     0.2494     34
 trtn*AVISITN   2              12    -0.6470     0.2552     34
 trtn*AVISITN   3               4    -0.3855     0.2630     34
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=18 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   3              12    -0.4677     0.2691     34

                      Least Squares Means
 
                       Analysis
 Effect         trtn   Visit (N)    t Value   Pr > |t|    Alpha

 trtn*AVISITN   1               4     -1.65     0.1091     0.05
 trtn*AVISITN   1              12     -2.47     0.0188     0.05
 trtn*AVISITN   2               4     -2.14     0.0397     0.05
 trtn*AVISITN   2              12     -2.54     0.0160     0.05
 trtn*AVISITN   3               4     -1.47     0.1519     0.05
 trtn*AVISITN   3              12     -1.74     0.0912     0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=18 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                          Analysis
    Effect         trtn   Visit (N)       Lower       Upper

    trtn*AVISITN   1               4    -1.1026      0.1160
    trtn*AVISITN   1              12    -1.3801     -0.1332
    trtn*AVISITN   2               4    -1.0400    -0.02653
    trtn*AVISITN   2              12    -1.1655     -0.1284
    trtn*AVISITN   3               4    -0.9199      0.1489
    trtn*AVISITN   3              12    -1.0146     0.07910


 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=18 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  1              4  1              12    0.2633
  trtn*AVISITN  1              4  2               4   0.03999
  trtn*AVISITN  1              4  2              12    0.1537
  trtn*AVISITN  1              4  3               4   -0.1078
  trtn*AVISITN  1              4  3              12  -0.02556
  trtn*AVISITN  1             12  2               4   -0.2233
  trtn*AVISITN  1             12  2              12   -0.1097
  trtn*AVISITN  1             12  3               4   -0.3712
  trtn*AVISITN  1             12  3              12   -0.2889
  trtn*AVISITN  2              4  2              12    0.1137
  trtn*AVISITN  2              4  3               4   -0.1478
  trtn*AVISITN  2              4  3              12  -0.06555
  trtn*AVISITN  2             12  3               4   -0.2615
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=18 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  1              4  1              12    0.3466
  trtn*AVISITN  1              4  2               4    0.3509
  trtn*AVISITN  1              4  2              12    0.3804
  trtn*AVISITN  1              4  3               4    0.3553
  trtn*AVISITN  1              4  3              12    0.3881
  trtn*AVISITN  1             12  2               4    0.3821
  trtn*AVISITN  1             12  2              12    0.3591
  trtn*AVISITN  1             12  3               4    0.3894
  trtn*AVISITN  1             12  3              12    0.3636
  trtn*AVISITN  2              4  2              12    0.2883
  trtn*AVISITN  2              4  3               4    0.3071
  trtn*AVISITN  2              4  3              12    0.3485
  trtn*AVISITN  2             12  3               4    0.3480
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=18 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  1              4  1              12    34     0.76
trtn*AVISITN  1              4  2               4    34     0.11
trtn*AVISITN  1              4  2              12  64.5     0.40
trtn*AVISITN  1              4  3               4    34    -0.30
trtn*AVISITN  1              4  3              12  65.7    -0.07
trtn*AVISITN  1             12  2               4  63.5    -0.58
trtn*AVISITN  1             12  2              12    34    -0.31
trtn*AVISITN  1             12  3               4  64.9    -0.95
trtn*AVISITN  1             12  3              12    34    -0.79
trtn*AVISITN  2              4  2              12    34     0.39
trtn*AVISITN  2              4  3               4    34    -0.48
trtn*AVISITN  2              4  3              12  67.2    -0.19
trtn*AVISITN  2             12  3               4  67.6    -0.75
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=18 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  1              4  1              12    0.4527
  trtn*AVISITN  1              4  2               4    0.9100
  trtn*AVISITN  1              4  2              12    0.6876
  trtn*AVISITN  1              4  3               4    0.7634
  trtn*AVISITN  1              4  3              12    0.9477
  trtn*AVISITN  1             12  2               4    0.5610
  trtn*AVISITN  1             12  2              12    0.7619
  trtn*AVISITN  1             12  3               4    0.3440
  trtn*AVISITN  1             12  3              12    0.4324
  trtn*AVISITN  2              4  2              12    0.6959
  trtn*AVISITN  2              4  3               4    0.6334
  trtn*AVISITN  2              4  3              12    0.8514
  trtn*AVISITN  2             12  3               4    0.4550
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=18 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  1              4  1              12    0.05
   trtn*AVISITN  1              4  2               4    0.05
   trtn*AVISITN  1              4  2              12    0.05
   trtn*AVISITN  1              4  3               4    0.05
   trtn*AVISITN  1              4  3              12    0.05
   trtn*AVISITN  1             12  2               4    0.05
   trtn*AVISITN  1             12  2              12    0.05
   trtn*AVISITN  1             12  3               4    0.05
   trtn*AVISITN  1             12  3              12    0.05
   trtn*AVISITN  2              4  2              12    0.05
   trtn*AVISITN  2              4  3               4    0.05
   trtn*AVISITN  2              4  3              12    0.05
   trtn*AVISITN  2             12  3               4    0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=18 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  1              4  1              12   -0.4411
  trtn*AVISITN  1              4  2               4   -0.6732
  trtn*AVISITN  1              4  2              12   -0.6062
  trtn*AVISITN  1              4  3               4   -0.8299
  trtn*AVISITN  1              4  3              12   -0.8005
  trtn*AVISITN  1             12  2               4   -0.9869
  trtn*AVISITN  1             12  2              12   -0.8395
  trtn*AVISITN  1             12  3               4   -1.1488
  trtn*AVISITN  1             12  3              12   -1.0278
  trtn*AVISITN  2              4  2              12   -0.4723
  trtn*AVISITN  2              4  3               4   -0.7719
  trtn*AVISITN  2              4  3              12   -0.7611
  trtn*AVISITN  2             12  3               4   -0.9560
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=18 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  1              4  1              12    0.9678
  trtn*AVISITN  1              4  2               4    0.7532
  trtn*AVISITN  1              4  2              12    0.9135
  trtn*AVISITN  1              4  3               4    0.6143
  trtn*AVISITN  1              4  3              12    0.7494
  trtn*AVISITN  1             12  2               4    0.5402
  trtn*AVISITN  1             12  2              12    0.6201
  trtn*AVISITN  1             12  3               4    0.4065
  trtn*AVISITN  1             12  3              12    0.4500
  trtn*AVISITN  2              4  2              12    0.6996
  trtn*AVISITN  2              4  3               4    0.4763
  trtn*AVISITN  2              4  3              12    0.6300
  trtn*AVISITN  2             12  3               4    0.4330
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=18 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  2             12  3              12   -0.1792
  trtn*AVISITN  3              4  3              12   0.08227

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  2             12  3              12    0.3142
  trtn*AVISITN  3              4  3              12    0.3040

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=18 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  2             12  3              12    34    -0.57
trtn*AVISITN  3              4  3              12    34     0.27

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  2             12  3              12    0.5722
  trtn*AVISITN  3              4  3              12    0.7883

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=18 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  2             12  3              12    0.05
   trtn*AVISITN  3              4  3              12    0.05

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  2             12  3              12   -0.8178
  trtn*AVISITN  3              4  3              12   -0.5356

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=18 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  2             12  3              12    0.4594
  trtn*AVISITN  3              4  3              12    0.7001
 
 
 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=19 -------------------------

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.TARGET_1            
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=19 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             39    10631001 10631002 10631003    
                           11601002 11601006 11601007    
                           13031001 13031004 13581001    
                           13581010 13581014 13991001    
                           13991002 13991004 13991007    
                           13991009 13991010 16591001    
                           16591003 16591006 17601002    
                           17601003 17601005 17601007    
                           17601012 17601014 17601025    
                           17661002 17661004 17661006    
                           19691001 19731001 19731002    
                           19731004 19731006 19831001    
                           19831005 19831008 19901003    
      trtn            3    1 2 3                         
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=19 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      AVISITN         2    4 12                          
      SSNRISN         2    1 2                           


                          Dimensions

              Covariance Parameters             3
              Columns in X                     21
              Columns in Z                      0
              Subjects                         39
              Max Obs per Subject               2
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=19 -------------------------

                      The Mixed Procedure

                    Number of Observations

          Number of Observations Read              78
          Number of Observations Used              78
          Number of Observations Not Used           0


                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       208.57170534                
          1              1       202.02534686      0.00000000


                   Convergence criteria met.                    
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=19 -------------------------

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.5746
                UN(2,1)     id           0.2048
                UN(2,2)     id           1.1882


                        Fit Statistics

             -2 Res Log Likelihood           202.0
             AIC (Smaller is Better)         208.0
             AICC (Smaller is Better)        208.4
             BIC (Smaller is Better)         213.0
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=19 -------------------------

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   2          6.55          0.0379


                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      BASE                  1      34      51.25    <.0001
      trtn                  2      34       0.91    0.4140
      AVISITN               1      34       0.30    0.5875
      trtn*AVISITN          2      34       0.25    0.7778
      BASE*AVISITN          1      34       0.21    0.6490
      SSNRISN               1      34       2.93    0.0958
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=19 -------------------------

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      AVISITN*SSNRISN       1      34       1.56    0.2199


                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   1               4    -0.5357     0.2742     34
 trtn*AVISITN   1              12    -0.5297     0.3943     34
 trtn*AVISITN   2               4    -0.4979     0.2281     34
 trtn*AVISITN   2              12    -0.4319     0.3280     34
 trtn*AVISITN   3               4    -0.3203     0.2405     34
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=19 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   3              12   -0.00269     0.3459     34

                      Least Squares Means
 
                       Analysis
 Effect         trtn   Visit (N)    t Value   Pr > |t|    Alpha

 trtn*AVISITN   1               4     -1.95     0.0590     0.05
 trtn*AVISITN   1              12     -1.34     0.1881     0.05
 trtn*AVISITN   2               4     -2.18     0.0360     0.05
 trtn*AVISITN   2              12     -1.32     0.1967     0.05
 trtn*AVISITN   3               4     -1.33     0.1918     0.05
 trtn*AVISITN   3              12     -0.01     0.9938     0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=19 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                          Analysis
    Effect         trtn   Visit (N)       Lower       Upper

    trtn*AVISITN   1               4    -1.0930     0.02154
    trtn*AVISITN   1              12    -1.3310      0.2717
    trtn*AVISITN   2               4    -0.9614    -0.03441
    trtn*AVISITN   2              12    -1.0984      0.2347
    trtn*AVISITN   3               4    -0.8091      0.1685
    trtn*AVISITN   3              12    -0.7056      0.7002


 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=19 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  1              4  1              12  -0.00607
  trtn*AVISITN  1              4  2               4  -0.03781
  trtn*AVISITN  1              4  2              12   -0.1038
  trtn*AVISITN  1              4  3               4   -0.2155
  trtn*AVISITN  1              4  3              12   -0.5331
  trtn*AVISITN  1             12  2               4  -0.03174
  trtn*AVISITN  1             12  2              12  -0.09778
  trtn*AVISITN  1             12  3               4   -0.2094
  trtn*AVISITN  1             12  3              12   -0.5270
  trtn*AVISITN  2              4  2              12  -0.06604
  trtn*AVISITN  2              4  3               4   -0.1776
  trtn*AVISITN  2              4  3              12   -0.4952
  trtn*AVISITN  2             12  3               4   -0.1116
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=19 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  1              4  1              12    0.4208
  trtn*AVISITN  1              4  2               4    0.3210
  trtn*AVISITN  1              4  2              12    0.4173
  trtn*AVISITN  1              4  3               4    0.3250
  trtn*AVISITN  1              4  3              12    0.4302
  trtn*AVISITN  1             12  2               4    0.4460
  trtn*AVISITN  1             12  2              12    0.4616
  trtn*AVISITN  1             12  3               4    0.4512
  trtn*AVISITN  1             12  3              12    0.4673
  trtn*AVISITN  2              4  2              12    0.3500
  trtn*AVISITN  2              4  3               4    0.2809
  trtn*AVISITN  2              4  3              12    0.4008
  trtn*AVISITN  2             12  3               4    0.3929
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=19 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  1              4  1              12    34    -0.01
trtn*AVISITN  1              4  2               4    34    -0.12
trtn*AVISITN  1              4  2              12  65.6    -0.25
trtn*AVISITN  1              4  3               4    34    -0.66
trtn*AVISITN  1              4  3              12  64.4    -1.24
trtn*AVISITN  1             12  2               4  53.9    -0.07
trtn*AVISITN  1             12  2              12    34    -0.21
trtn*AVISITN  1             12  3               4  55.7    -0.46
trtn*AVISITN  1             12  3              12    34    -1.13
trtn*AVISITN  2              4  2              12    34    -0.19
trtn*AVISITN  2              4  3               4    34    -0.63
trtn*AVISITN  2              4  3              12  58.3    -1.24
trtn*AVISITN  2             12  3               4  61.9    -0.28
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=19 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  1              4  1              12    0.9886
  trtn*AVISITN  1              4  2               4    0.9069
  trtn*AVISITN  1              4  2              12    0.8043
  trtn*AVISITN  1              4  3               4    0.5118
  trtn*AVISITN  1              4  3              12    0.2198
  trtn*AVISITN  1             12  2               4    0.9435
  trtn*AVISITN  1             12  2              12    0.8335
  trtn*AVISITN  1             12  3               4    0.6444
  trtn*AVISITN  1             12  3              12    0.2674
  trtn*AVISITN  2              4  2              12    0.8515
  trtn*AVISITN  2              4  3               4    0.5313
  trtn*AVISITN  2              4  3              12    0.2215
  trtn*AVISITN  2             12  3               4    0.7773
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=19 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  1              4  1              12    0.05
   trtn*AVISITN  1              4  2               4    0.05
   trtn*AVISITN  1              4  2              12    0.05
   trtn*AVISITN  1              4  3               4    0.05
   trtn*AVISITN  1              4  3              12    0.05
   trtn*AVISITN  1             12  2               4    0.05
   trtn*AVISITN  1             12  2              12    0.05
   trtn*AVISITN  1             12  3               4    0.05
   trtn*AVISITN  1             12  3              12    0.05
   trtn*AVISITN  2              4  2              12    0.05
   trtn*AVISITN  2              4  3               4    0.05
   trtn*AVISITN  2              4  3              12    0.05
   trtn*AVISITN  2             12  3               4    0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=19 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  1              4  1              12   -0.8613
  trtn*AVISITN  1              4  2               4   -0.6902
  trtn*AVISITN  1              4  2              12   -0.9371
  trtn*AVISITN  1              4  3               4   -0.8759
  trtn*AVISITN  1              4  3              12   -1.3923
  trtn*AVISITN  1             12  2               4   -0.9259
  trtn*AVISITN  1             12  2              12   -1.0359
  trtn*AVISITN  1             12  3               4   -1.1133
  trtn*AVISITN  1             12  3              12   -1.4767
  trtn*AVISITN  2              4  2              12   -0.7774
  trtn*AVISITN  2              4  3               4   -0.7485
  trtn*AVISITN  2              4  3              12   -1.2974
  trtn*AVISITN  2             12  3               4   -0.8971
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=19 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  1              4  1              12    0.8491
  trtn*AVISITN  1              4  2               4    0.6145
  trtn*AVISITN  1              4  2              12    0.7294
  trtn*AVISITN  1              4  3               4    0.4450
  trtn*AVISITN  1              4  3              12    0.3262
  trtn*AVISITN  1             12  2               4    0.8624
  trtn*AVISITN  1             12  2              12    0.8403
  trtn*AVISITN  1             12  3               4    0.6946
  trtn*AVISITN  1             12  3              12    0.4228
  trtn*AVISITN  2              4  2              12    0.6453
  trtn*AVISITN  2              4  3               4    0.3932
  trtn*AVISITN  2              4  3              12    0.3069
  trtn*AVISITN  2             12  3               4    0.6738
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=19 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  2             12  3              12   -0.4292
  trtn*AVISITN  3              4  3              12   -0.3176

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  2             12  3              12    0.4039
  trtn*AVISITN  3              4  3              12    0.3691

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=19 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  2             12  3              12    34    -1.06
trtn*AVISITN  3              4  3              12    34    -0.86

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  2             12  3              12    0.2955
  trtn*AVISITN  3              4  3              12    0.3956

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=19 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  2             12  3              12    0.05
   trtn*AVISITN  3              4  3              12    0.05

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  2             12  3              12   -1.2501
  trtn*AVISITN  3              4  3              12   -1.0677

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=19 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  2             12  3              12    0.3917
  trtn*AVISITN  3              4  3              12    0.4325
 
 
 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=20 -------------------------

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.TARGET_1            
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=20 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             39    10631001 10631002 10631003    
                           11601002 11601006 11601007    
                           13031001 13031004 13581001    
                           13581010 13581014 13991001    
                           13991002 13991004 13991007    
                           13991009 13991010 16591001    
                           16591003 16591006 17601002    
                           17601003 17601005 17601007    
                           17601012 17601014 17601025    
                           17661002 17661004 17661006    
                           19691001 19731001 19731002    
                           19731004 19731006 19831001    
                           19831005 19831008 19901003    
      trtn            3    1 2 3                         
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=20 -------------------------

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      AVISITN         2    4 12                          
      SSNRISN         2    1 2                           


                          Dimensions

              Covariance Parameters             3
              Columns in X                     21
              Columns in Z                      0
              Subjects                         39
              Max Obs per Subject               2
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=20 -------------------------

                      The Mixed Procedure

                    Number of Observations

          Number of Observations Read              78
          Number of Observations Used              78
          Number of Observations Not Used           0


                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       194.70455464                
          1              1       182.33775682      0.00000000


                   Convergence criteria met.                    
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=20 -------------------------

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.6704
                UN(2,1)     id           0.3940
                UN(2,2)     id           0.7672


                        Fit Statistics

             -2 Res Log Likelihood           182.3
             AIC (Smaller is Better)         188.3
             AICC (Smaller is Better)        188.7
             BIC (Smaller is Better)         193.3
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=20 -------------------------

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   2         12.37          0.0021


                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      BASE                  1      34      42.58    <.0001
      trtn                  2      34       0.18    0.8349
      AVISITN               1      34       1.17    0.2867
      trtn*AVISITN          2      34       0.72    0.4929
      BASE*AVISITN          1      34       0.52    0.4772
      SSNRISN               1      34       3.48    0.0708
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=20 -------------------------

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      AVISITN*SSNRISN       1      34       2.52    0.1214


                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   1               4    -0.5030     0.2962     34
 trtn*AVISITN   1              12    -0.5760     0.3169     34
 trtn*AVISITN   2               4    -0.4678     0.2464     34
 trtn*AVISITN   2              12    -0.8121     0.2636     34
 trtn*AVISITN   3               4    -0.4870     0.2598     34
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=20 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                       Analysis                Standard
 Effect         trtn   Visit (N)    Estimate      Error     DF

 trtn*AVISITN   3              12    -0.9748     0.2779     34

                      Least Squares Means
 
                       Analysis
 Effect         trtn   Visit (N)    t Value   Pr > |t|    Alpha

 trtn*AVISITN   1               4     -1.70     0.0986     0.05
 trtn*AVISITN   1              12     -1.82     0.0779     0.05
 trtn*AVISITN   2               4     -1.90     0.0661     0.05
 trtn*AVISITN   2              12     -3.08     0.0041     0.05
 trtn*AVISITN   3               4     -1.87     0.0695     0.05
 trtn*AVISITN   3              12     -3.51     0.0013     0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=20 -------------------------

                      The Mixed Procedure

                      Least Squares Means
 
                          Analysis
    Effect         trtn   Visit (N)       Lower       Upper

    trtn*AVISITN   1               4    -1.1050     0.09890
    trtn*AVISITN   1              12    -1.2199     0.06795
    trtn*AVISITN   2               4    -0.9684     0.03289
    trtn*AVISITN   2              12    -1.3477     -0.2765
    trtn*AVISITN   3               4    -1.0150     0.04096
    trtn*AVISITN   3              12    -1.5396     -0.4100


 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=20 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  1              4  1              12   0.07296
  trtn*AVISITN  1              4  2               4  -0.03527
  trtn*AVISITN  1              4  2              12    0.3091
  trtn*AVISITN  1              4  3               4  -0.01603
  trtn*AVISITN  1              4  3              12    0.4717
  trtn*AVISITN  1             12  2               4   -0.1082
  trtn*AVISITN  1             12  2              12    0.2361
  trtn*AVISITN  1             12  3               4  -0.08900
  trtn*AVISITN  1             12  3              12    0.3988
  trtn*AVISITN  2              4  2              12    0.3444
  trtn*AVISITN  2              4  3               4   0.01923
  trtn*AVISITN  2              4  3              12    0.5070
  trtn*AVISITN  2             12  3               4   -0.3251
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=20 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  1              4  1              12    0.2916
  trtn*AVISITN  1              4  2               4    0.3467
  trtn*AVISITN  1              4  2              12    0.3750
  trtn*AVISITN  1              4  3               4    0.3510
  trtn*AVISITN  1              4  3              12    0.3823
  trtn*AVISITN  1             12  2               4    0.3802
  trtn*AVISITN  1             12  2              12    0.3709
  trtn*AVISITN  1             12  3               4    0.3861
  trtn*AVISITN  1             12  3              12    0.3755
  trtn*AVISITN  2              4  2              12    0.2425
  trtn*AVISITN  2              4  3               4    0.3034
  trtn*AVISITN  2              4  3              12    0.3416
  trtn*AVISITN  2             12  3               4    0.3402
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=20 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  1              4  1              12    34     0.25
trtn*AVISITN  1              4  2               4    34    -0.10
trtn*AVISITN  1              4  2              12  58.1     0.82
trtn*AVISITN  1              4  3               4    34    -0.05
trtn*AVISITN  1              4  3              12    59     1.23
trtn*AVISITN  1             12  2               4  55.9    -0.28
trtn*AVISITN  1             12  2              12    34     0.64
trtn*AVISITN  1             12  3               4  57.4    -0.23
trtn*AVISITN  1             12  3              12    34     1.06
trtn*AVISITN  2              4  2              12    34     1.42
trtn*AVISITN  2              4  3               4    34     0.06
trtn*AVISITN  2              4  3              12    61     1.48
trtn*AVISITN  2             12  3               4  61.8    -0.96
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=20 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  1              4  1              12    0.8039
  trtn*AVISITN  1              4  2               4    0.9196
  trtn*AVISITN  1              4  2              12    0.4131
  trtn*AVISITN  1              4  3               4    0.9638
  trtn*AVISITN  1              4  3              12    0.2221
  trtn*AVISITN  1             12  2               4    0.7769
  trtn*AVISITN  1             12  2              12    0.5286
  trtn*AVISITN  1             12  3               4    0.8185
  trtn*AVISITN  1             12  3              12    0.2958
  trtn*AVISITN  2              4  2              12    0.1647
  trtn*AVISITN  2              4  3               4    0.9498
  trtn*AVISITN  2              4  3              12    0.1429
  trtn*AVISITN  2             12  3               4    0.3429
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=20 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  1              4  1              12    0.05
   trtn*AVISITN  1              4  2               4    0.05
   trtn*AVISITN  1              4  2              12    0.05
   trtn*AVISITN  1              4  3               4    0.05
   trtn*AVISITN  1              4  3              12    0.05
   trtn*AVISITN  1             12  2               4    0.05
   trtn*AVISITN  1             12  2              12    0.05
   trtn*AVISITN  1             12  3               4    0.05
   trtn*AVISITN  1             12  3              12    0.05
   trtn*AVISITN  2              4  2              12    0.05
   trtn*AVISITN  2              4  3               4    0.05
   trtn*AVISITN  2              4  3              12    0.05
   trtn*AVISITN  2             12  3               4    0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=20 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  1              4  1              12   -0.5196
  trtn*AVISITN  1              4  2               4   -0.7399
  trtn*AVISITN  1              4  2              12   -0.4415
  trtn*AVISITN  1              4  3               4   -0.7294
  trtn*AVISITN  1              4  3              12   -0.2933
  trtn*AVISITN  1             12  2               4   -0.8698
  trtn*AVISITN  1             12  2              12   -0.5177
  trtn*AVISITN  1             12  3               4   -0.8621
  trtn*AVISITN  1             12  3              12   -0.3644
  trtn*AVISITN  2              4  2              12   -0.1485
  trtn*AVISITN  2              4  3               4   -0.5974
  trtn*AVISITN  2              4  3              12   -0.1761
  trtn*AVISITN  2             12  3               4   -1.0052
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=20 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  1              4  1              12    0.6655
  trtn*AVISITN  1              4  2               4    0.6694
  trtn*AVISITN  1              4  2              12    1.0597
  trtn*AVISITN  1              4  3               4    0.6974
  trtn*AVISITN  1              4  3              12    1.2368
  trtn*AVISITN  1             12  2               4    0.6533
  trtn*AVISITN  1             12  2              12    0.9899
  trtn*AVISITN  1             12  3               4    0.6841
  trtn*AVISITN  1             12  3              12    1.1620
  trtn*AVISITN  2              4  2              12    0.8372
  trtn*AVISITN  2              4  3               4    0.6358
  trtn*AVISITN  2              4  3              12    1.1901
  trtn*AVISITN  2             12  3               4    0.3549
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=20 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Estimate

  trtn*AVISITN  2             12  3              12    0.1626
  trtn*AVISITN  3              4  3              12    0.4878

              Differences of Least Squares Means
 
                      Analysis           Analysis    Standard
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Error

  trtn*AVISITN  2             12  3              12    0.3246
  trtn*AVISITN  3              4  3              12    0.2558

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=20 -------------------------

                      The Mixed Procedure

               Differences of Least Squares Means
 
                    Analysis           Analysis
Effect        trtn  Visit (N)   _trtn  Visit (N)     DF  t Value

trtn*AVISITN  2             12  3              12    34     0.50
trtn*AVISITN  3              4  3              12    34     1.91

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)   Pr > |t|

  trtn*AVISITN  2             12  3              12    0.6195
  trtn*AVISITN  3              4  3              12    0.0650

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=20 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                       Analysis           Analysis
   Effect        trtn  Visit (N)   _trtn  Visit (N)    Alpha

   trtn*AVISITN  2             12  3              12    0.05
   trtn*AVISITN  3              4  3              12    0.05

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Lower

  trtn*AVISITN  2             12  3              12   -0.4970
  trtn*AVISITN  3              4  3              12  -0.03197

 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

------------------------ Imputation=20 -------------------------

                      The Mixed Procedure

              Differences of Least Squares Means
 
                      Analysis           Analysis
  Effect        trtn  Visit (N)   _trtn  Visit (N)      Upper

  trtn*AVISITN  2             12  3              12    0.8223
  trtn*AVISITN  3              4  3              12    1.0075
 
 
 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

----------------- Analysis Visit (N)=12 trtn=1 -----------------

                    The MIANALYZE Procedure

                       Model Information

            Data Set                  WORK.LSDIFFS2
            Number of Imputations     20           


             Variance Information (20 Imputations)
 
             -----------------Variance-----------------
Parameter         Between         Within          Total       DF

ESTIMATE         0.188696       0.207390       0.405521   79.593

 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

----------------- Analysis Visit (N)=12 trtn=1 -----------------

                    The MIANALYZE Procedure

             Variance Information (20 Imputations)
 
                     Relative       Fraction
                     Increase        Missing       Relative
    Parameter     in Variance    Information     Efficiency

    ESTIMATE         0.955356       0.500968       0.975564


              Parameter Estimates (20 Imputations)
 
Parameter      Estimate      Std Error    95% Confidence Limits

ESTIMATE      -0.203737       0.636805     -1.47112     1.063645

 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

----------------- Analysis Visit (N)=12 trtn=1 -----------------

                    The MIANALYZE Procedure

             Parameter Estimates (20 Imputations)
 
        Parameter      DF        Minimum        Maximum

        ESTIMATE   79.593      -0.902753       0.713112

             Parameter Estimates (20 Imputations)
 
                                      t for H0:
     Parameter        Theta0   Parameter=Theta0   Pr > |t|

     ESTIMATE              0              -0.32     0.7499
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

----------------- Analysis Visit (N)=12 trtn=2 -----------------

                    The MIANALYZE Procedure

                       Model Information

            Data Set                  WORK.LSDIFFS2
            Number of Imputations     20           


             Variance Information (20 Imputations)
 
             -----------------Variance-----------------
Parameter         Between         Within          Total       DF

ESTIMATE         0.072597       0.154921       0.231148   174.71

 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

----------------- Analysis Visit (N)=12 trtn=2 -----------------

                    The MIANALYZE Procedure

             Variance Information (20 Imputations)
 
                     Relative       Fraction
                     Increase        Missing       Relative
    Parameter     in Variance    Information     Efficiency

    ESTIMATE         0.492037       0.337318       0.983414


              Parameter Estimates (20 Imputations)
 
Parameter      Estimate      Std Error    95% Confidence Limits

ESTIMATE      -0.119316       0.480778     -1.06820     0.829565

 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

----------------- Analysis Visit (N)=12 trtn=2 -----------------

                    The MIANALYZE Procedure

             Parameter Estimates (20 Imputations)
 
        Parameter      DF        Minimum        Maximum

        ESTIMATE   174.71      -0.553670       0.346863

             Parameter Estimates (20 Imputations)
 
                                      t for H0:
     Parameter        Theta0   Parameter=Theta0   Pr > |t|

     ESTIMATE              0              -0.25     0.8043
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

----------------- Analysis Visit (N)=12 trtn=1 -----------------

                    The MIANALYZE Procedure

                       Model Information

            Data Set                  WORK.LSMEANS2
            Number of Imputations     20           


             Variance Information (20 Imputations)
 
             -----------------Variance-----------------
Parameter         Between         Within          Total       DF

ESTIMATE         0.026909       0.147646       0.175900   736.42

 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

----------------- Analysis Visit (N)=12 trtn=1 -----------------

                    The MIANALYZE Procedure

             Variance Information (20 Imputations)
 
                     Relative       Fraction
                     Increase        Missing       Relative
    Parameter     in Variance    Information     Efficiency

    ESTIMATE         0.191363       0.162896       0.991921


              Parameter Estimates (20 Imputations)
 
Parameter      Estimate      Std Error    95% Confidence Limits

ESTIMATE      -0.752859       0.419405     -1.57623     0.070512

 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

----------------- Analysis Visit (N)=12 trtn=1 -----------------

                    The MIANALYZE Procedure

             Parameter Estimates (20 Imputations)
 
        Parameter      DF        Minimum        Maximum

        ESTIMATE   736.42      -1.125065      -0.478864

             Parameter Estimates (20 Imputations)
 
                                      t for H0:
     Parameter        Theta0   Parameter=Theta0   Pr > |t|

     ESTIMATE              0              -1.80     0.0731
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

----------------- Analysis Visit (N)=12 trtn=2 -----------------

                    The MIANALYZE Procedure

                       Model Information

            Data Set                  WORK.LSMEANS2
            Number of Imputations     20           


             Variance Information (20 Imputations)
 
             -----------------Variance-----------------
Parameter         Between         Within          Total       DF

ESTIMATE         0.044284       0.102145       0.148643   194.17

 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

----------------- Analysis Visit (N)=12 trtn=2 -----------------

                    The MIANALYZE Procedure

             Variance Information (20 Imputations)
 
                     Relative       Fraction
                     Increase        Missing       Relative
    Parameter     in Variance    Information     Efficiency

    ESTIMATE         0.455217       0.319788       0.984262


              Parameter Estimates (20 Imputations)
 
Parameter      Estimate      Std Error    95% Confidence Limits

ESTIMATE      -0.668438       0.385543     -1.42883     0.091951

 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

----------------- Analysis Visit (N)=12 trtn=2 -----------------

                    The MIANALYZE Procedure

             Parameter Estimates (20 Imputations)
 
        Parameter      DF        Minimum        Maximum

        ESTIMATE   194.17      -1.142617      -0.308763

             Parameter Estimates (20 Imputations)
 
                                      t for H0:
     Parameter        Theta0   Parameter=Theta0   Pr > |t|

     ESTIMATE              0              -1.73     0.0845
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

----------------- Analysis Visit (N)=12 trtn=3 -----------------

                    The MIANALYZE Procedure

                       Model Information

            Data Set                  WORK.LSMEANS2
            Number of Imputations     20           


             Variance Information (20 Imputations)
 
             -----------------Variance-----------------
Parameter         Between         Within          Total       DF

ESTIMATE         0.191204       0.113586       0.314351   46.581

 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

----------------- Analysis Visit (N)=12 trtn=3 -----------------

                    The MIANALYZE Procedure

             Variance Information (20 Imputations)
 
                     Relative       Fraction
                     Increase        Missing       Relative
    Parameter     in Variance    Information     Efficiency

    ESTIMATE         1.767504       0.653239       0.968371


              Parameter Estimates (20 Imputations)
 
Parameter      Estimate      Std Error    95% Confidence Limits

ESTIMATE      -0.549122       0.560670     -1.67731     0.579069

 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.2
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

----------------- Analysis Visit (N)=12 trtn=3 -----------------

                    The MIANALYZE Procedure

             Parameter Estimates (20 Imputations)
 
        Parameter      DF        Minimum        Maximum

        ESTIMATE   46.581      -1.489480       0.003985

             Parameter Estimates (20 Imputations)
 
                                      t for H0:
     Parameter        Theta0   Parameter=Theta0   Pr > |t|

     ESTIMATE              0              -0.98     0.3324
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: Time-dependent multiple imputation repeated measures 
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
